Emmaus Life Sciences (EMMA) 10-K 29 Dec 14 2014 FY Annual report Financial data

Document_And_Entity_Informatio

Document And Entity Information (USD $)	12 Months Ended
	Sep. 30, 2014	Dec. 29, 2014	Mar. 31, 2014
Document Information [Line Items]
Entity Registrant Name	CNS RESPONSE, INC.
Entity Central Index Key	822370
Current Fiscal Year End Date	-21
Entity Filer Category	Smaller Reporting Company
Trading Symbol	CNSO
Entity Common Stock, Shares Outstanding		101,667,409
Document Type	10-K
Amendment Flag	FALSE
Document Period End Date	30-Sep-14
Document Fiscal Year Focus	2014
Document Fiscal Period Focus	FY
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Public Float			$28,787,500

CONSOLIDATED_BALANCE_SHEETS

CONSOLIDATED BALANCE SHEETS (USD $)	Sep. 30, 2014	Sep. 30, 2013
CURRENT ASSETS:
Cash	$1,240,600	$1,273,600
Accounts receivable (net of allowance for doubtful accounts of $1,200 and $5,900 as of September 30, 2014 and 2013 respectively)	9,300	26,600
Prepaids and other assets	58,200	63,700
Total current assets	1,308,100	1,363,900
Furniture and equipment, net	8,700	16,800
Other assets	19,300	21,500
TOTAL ASSETS	1,336,100	1,402,200
CURRENT LIABILITIES:
Accounts payable (including $41,300 and $66,700 to related parties as of September 30, 2014 and 2013 respectively)	868,900	2,493,200
Accrued liabilities	26,200	24,200
Accrued compensation (including $71,700 and $294,500 to related parties as of September 30, 2014 and 2013 respectively)	342,000	763,100
Deferred revenue - grant funds	45,900	0
Derivative liability	153,100	0
Current portion of long-term debt	3,500	7,200
Liabilities of discontinued operation	177,200	268,500
Total current liabilities	1,616,800	3,556,200
LONG-TERM LIABILITIES
Secured Convertible Debt (net of discounts $174,200 and $0 as of September 30, 2014 and 2013 respectively)	1,475,800	0
Accrued Interest	2,600	0
Capital lease	2,500	6,000
Total long-term liabilities	1,480,900	6,000
TOTAL LIABILITIES	3,097,700	3,562,200
COMMITMENTS AND CONTINGENCIES
STOCKHOLDERS' DEFICIT:
Common stock, $0.001 par value; authorized 180,000,000 and 150,000,000 shares and issued and outstanding 101,667,409 and 92,716,562 shares as of September 30, 2014 and 2013 respectively	101,700	92,700
Additional paid-in capital	57,350,200	54,298,000
Accumulated deficit	-59,213,500	-56,550,700
Total stockholders' deficit	-1,761,600	-2,160,000
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	$1,336,100	$1,402,200

CONSOLIDATED_BALANCE_SHEETS_Pa

CONSOLIDATED BALANCE SHEETS [Parenthetical] (USD $)	Sep. 30, 2014	Sep. 30, 2013
Allowance for doubtful accounts (in dollars)	$1,200	$5,900
Accounts payable due to related parties (in dollars)	41,300	66,700
Accrued compensation liability to related party (in dollars)	71,700	294,500
Secured convertible debt, net of discounts (in dollars)	$174,200	$0
Common stock, par value (in dollars per share)	$0.00	$0.00
Common stock, shares authorized	180,000,000	150,000,000
Common stock, shares issued	101,667,409	92,716,562
Common stock, shares outstanding	101,667,409	92,716,562

CONSOLIDATED_STATEMENTS_OF_OPE

CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)	12 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
REVENUES
Neurometric Services	$135,100	$130,900
OPERATING EXPENSES
Cost of neurometric service revenues	73,000	142,600
Research	116,200	167,900
Product development	1,338,500	1,119,500
Sales and marketing	390,200	347,500
General and administrative	2,034,000	2,554,000
Total operating expenses	3,951,900	4,331,500
OPERATING LOSS	-3,816,800	-4,200,600
OTHER INCOME (EXPENSE)
Interest expense, net	-11,700	-1,288,200
Gain on extinguishment of debt	1,105,200	556,300
Financing fees	-1,800	-62,100
Offering costs	0	-2,500
Inducement to convert debt	0	-5,792,500
Gain (loss) on derivative liabilities	26,100	-97,600
Other miscellaneous income - write backs	44,100	0
Total other income (expense)	1,161,900	-6,686,600
LOSS BEFORE PROVISION FOR INCOME TAXES	-2,654,900	-10,887,200
Provision for income taxes	5,200	800
LOSS FROM CONTINUING OPERATIONS	-2,660,100	-10,888,000
Loss from discontinued operations	-2,700	-19,400
NET LOSS	($2,662,800)	($10,907,400)
BASIC AND DILUTED NET LOSS PER SHARE
From continuing operations (in dollars per share)	($0.03)	($0.14)
From discontinued operations (in dollars per share)	$0	$0
Combined Net Loss (in dollars per share)	($0.03)	($0.14)
WEIGHTED AVERAGE SHARES OUTSTANDING:
Basic and diluted (in shares)	99,326,519	75,800,179

CONSOLIDATED_STATEMENTS_OF_CHA

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT (USD $)	Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Accumulated Deficit [Member]
Balance at Sep. 30, 2012	($13,074,700)	$1,900	$32,566,700	($45,643,300)
Balance (in shares) at Sep. 30, 2012		1,914,175
Stock-based compensation	1,257,300	0	1,257,300	0
Valuation of warrants issued for debt	30,400	0	30,400	0
Stock issued for officer's salaries	7,900	200	7,700	0
Stock issued for officer's salaries (in shares)		165,790
October 2010 Notes: Senior subordinated convertible notes	3,789,200	14,200	3,775,000	0
October 2010 Notes: Senior subordinated convertible notes (in shares)		14,246,852
January 2011 Notes: Subordinated convertible notes	3,000,600	8,500	2,992,100	0
January 2011 Notes: Subordinated convertible notes (in shares)		8,503,003
October 2011 Notes: Subordinated convertible notes	2,301,400	9,200	2,292,200	0
October 2011 Notes: Subordinated convertible notes (in shares)		9,205,680
February 2012 Notes: Unsecured convertible note	101,900	400	101,500	0
February 2012 Notes: Unsecured convertible note (in shares)		407,700
October 2012 Notes: Unsecured convertible notes	2,080,000	44,100	2,035,900	0
October 2012 Notes: Unsecured convertible notes (in shares)		44,085,044
Stock issued for private placement of shares	2,958,800	12,200	2,946,600	0
Stock issued for private placement of shares (in shares)		12,180,000
Stock issued in lieu of cash to creditors	502,100	2,000	500,100	0
Stock issued in lieu of cash to creditors (in shares)		2,008,318
Inducement to convert debt	5,792,500	0	5,792,500	0
Net loss	-10,907,400	0	0	-10,907,400
Balance at Sep. 30, 2013	-2,160,000	92,700	54,298,000	-56,550,700
Balance (in shares) at Sep. 30, 2013		92,716,562
Stock-based compensation	1,008,700	0	1,008,700	0
Stock issued for private placement of shares	1,691,000	7,000	1,684,000	0
Stock issued for private placement of shares (in shares)		6,940,000
Stock issued in lieu of cash to creditors	361,500	1,400	360,100	0
Stock issued in lieu of cash to creditors (in shares)		1,446,380
Stock issued for cashless exercise of warrants	0	600	-600	0
Stock issued for cashless exercise of warrants (in shares)		564,467
Net loss	-2,662,800	0	0	-2,662,800
Balance at Sep. 30, 2014	($1,761,600)	$101,700	$57,350,200	($59,213,500)
Balance (in shares) at Sep. 30, 2014		101,667,409

CONSOLIDATED_STATEMENTS_OF_CAS

CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	12 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
OPERATING ACTIVITIES:
Net loss	($2,662,800)	($10,907,400)
Adjustments to reconcile net loss to net cash used in operating activities:
Net loss from discontinued operations	2,700	19,400
Depreciation and amortization	10,300	13,000
Amortization of discount on bridge notes issued	5,000	662,300
Loss (gain) on derivative liability valuation	-26,100	97,600
Stock based compensation	1,008,700	1,257,300
Gain on extinguishment of debt	-1,105,200	-556,300
Inducement to convert debt	0	5,792,500
Issuance of warrants for financing services	0	30,400
Non-cash interest expense	2,600	622,200
Changes in operating assets and liabilities:
Accounts receivable	17,300	-14,200
Prepaids and other	5,500	-20,000
Accounts payable and accrued liabilities	-153,900	-63,400
Deferred revenue grant funds	45,900	0
Deferred compensation	-421,100	30,400
Net cash used in operating activities	-3,271,100	-3,036,200
INVESTING ACTIVITIES:
Disposal of equipment	0	1,400
Net cash provided by investing activities	0	1,400
FINANCING ACTIVITIES:
Repayment of a capital lease	-7,200	-4,700
Net proceeds from sale of common stock	1,691,000	2,958,800
Net proceeds from sale of bridge notes	1,648,300	1,368,300
Net cash provided by financing activities	3,332,100	4,322,400
Net cash provided by continuing operations	61,000	1,287,600
DISCONTINUED OPERATIONS
Net cash used in discontinued operations	-94,000	-21,700
NET INCREASE (DECREASE) IN CASH	-33,000	1,265,900
CASH- BEGINNING OF YEAR	1,273,600	7,700
CASH- END OF YEAR	1,240,600	1,273,600
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Cash paid during the period for: Interest	4,200	3,600
Cash paid during the period for: Income taxes	5,200	800
Non-cash financing activities:
Offering costs	0	2,500
Shares issued for officer salaries payable	0	7,900
Shares issued on conversion of promissory notes and accrued interest	0	11,273,100
Shares issued for extinguishment of liabilities	361,500	502,100
Shares issued for cashless exercise of warrants	$600	$0

NATURE_OF_OPERATIONS

NATURE OF OPERATIONS	12 Months Ended
	Sep. 30, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Nature of Operations [Text Block]	1. NATURE OF OPERATIONS
	Organization and Nature of Operations
	CNS Response, Inc. (“CNS,” “we,” “us,” “our,” or the “Company”) was incorporated in Delaware on March 20, 1987, under the name Age Research, Inc.  Prior to January 16, 2007, the Company (then called Strativation, Inc.) was a “shell company” with nominal assets and our sole business was to identify, evaluate and investigate various companies to acquire or with which to merge.  On January 16, 2007, the Company entered into an Agreement and Plan of Merger (the “Merger Agreement”) with CNS Response, Inc., a California corporation formed on January 11, 2000 (“CNS California”), and CNS Merger Corporation, a California corporation and the Company’s wholly-owned subsidiary (“MergerCo”) pursuant to which the Company agreed to acquire CNS California in a merger transaction wherein MergerCo would merge with and into CNS California, with CNS California being the surviving corporation (the “Merger”). On March 7, 2007, the Merger closed, CNS California became a wholly-owned subsidiary of the Company, and on the same date the corporate name was changed from Strativation, Inc. to CNS Response, Inc.
	The Company is a clinical decision support company with a patented commercial neurometric platform to predict drug response for the treatment of brain disorders, including depression, anxiety, bipolar disorder and post-traumatic stress disorder (“PTSD”).  The Company has commenced a reimbursed 2,000 patient trial at Walter Reed National Military Medical Center (“Walter Reed”) and Fort Belvoir Community Hospital (“Fort Belvoir”) focused on patients with depression, PTSD and mild traumatic brain injury in order to support clinical decisions in the treatment of depression and related disorders.  We are being reimbursed by Walter Reed at a study-specific rate which includes a prorated element for study expenses for each Psychiatric Electroencephalographic Evaluation Registry (“PEER”) Outcome report rendered in the study. Enrollment of study subjects commenced in May 2013, and has continued through May 15, 2014. On May 15, 2014, the study’s principal investigator was directed to suspend enrollment of new subjects into the study pending further investigation of findings stemming from a routine audit. Treatment and tracking of individuals already enrolled in the clinical trial were allowed to continue. The Company has been supporting Investigating Officer’s requests for information via the study leader, Dr. Brett Schneider. We have been advised by WRNMMC leadership that the investigation should complete during August 2014 and study enrollment should resume shortly thereafter.
	The Company acquired the Neuro-Therapy Clinic, Inc. (“NTC”) on January 15, 2008, to provide behavioral health care services.  NTC’s operations were discontinued effective September 30, 2012. (Refer to Note 3. Discontinued Operations).
	At the Company’s 2014 annual meeting of stockholders, held on May 13, 2014 (the “2014 Annual Meeting”), the Company’s common stockholders voted to reappoint the Company’s existing board of directors (the “Board”) to serve until the next annual meeting and until any successor is elected and qualified.
	Going Concern Uncertainty
	The accompanying consolidated financial statements have been prepared in conformity with U.S. generally accepted accounting principles (“GAAP”), which contemplate continuation of the Company as a going concern. The Company has a limited operating history and its operations are subject to certain problems, expenses, difficulties, delays, complications, risks and uncertainties frequently encountered in the operation of a new business. These risks include the ability to obtain adequate financing on a timely basis, the failure to develop or supply technology or services to meet the demands of the marketplace, the failure to attract and retain qualified personnel, competition within the industry, government regulation and the general strength of regional and national economies.
	The Company’s continued operating losses and limited capital raise substantial doubt about its ability to continue as a going concern. The Company has limited cash resources for its operations and will need to raise additional funds to meet its obligations as they become due.
	To date, the Company has financed its cash requirements primarily from debt and equity financings.  The Company will need to raise additional funds immediately to continue its operations and to raise substantial additional funds before the Company can increase demand for its PEER Online services (formerly known as rEEG services). Until it can generate a sufficient amount of revenues to finance its cash requirements, which it may never do, the Company has to finance future cash needs primarily through public or private equity offerings, debt financings, borrowings or strategic collaborations. The Company’s liquidity and capital requirements depend on several factors, including the rate of market acceptance of its services, the future profitability of the Company, the rate of growth of the Company’s business and other factors described elsewhere in this Annual Report on Form 10-K.  The Company continues to explore additional sources of capital but there is substantial doubt as to whether any financing arrangement will be available in amounts and on terms acceptable to the Company to permit it to continue operations. The accompanying audited consolidated financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.
	Between October 4, 2013 and July 23, 2014, the Company issued an aggregate of 6,940,000 shares of its Common Stock, at a price of $0.25 per share, in private placements to an aggregate of 20 accredited investors. The gross proceeds to the Company were $1,735,000, net of $44,000 in placement agent fees for net proceeds to the Company of $1,691,000. Furthermore between September 22 and 29, 2014 the Company issued secured convertible debt in the aggregate principal amount of $1,650,000. For the 2014 fiscal year the aggregate gross proceeds to the Company were $3,385,000 from the combined equity and debt offerings.

SUMMARY_OF_SIGNIFICANT_ACCOUNT

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	12 Months Ended
	Sep. 30, 2014
Accounting Policies [Abstract]
Significant Accounting Policies [Text Block]	2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
	Basis of Presentation
	The accompanying consolidated financial statements of the Company have been prepared pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (the “SEC”) and are in accordance with accounting principles generally accepted in the United States of America.
	Basis of Consolidation
	The audited consolidated financial statements include the accounts of the Company, an inactive parent company, and its wholly owned subsidiaries CNS California and NTC, which is accounted for as a discontinued operation (Refer to Note 3.Discontinued Operations Transaction). All significant intercompany transactions have been eliminated on consolidation.
	Use of Estimates
	The preparation of the consolidated financial statements requires management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenue and expense, and related disclosure of contingent assets and liabilities. On an ongoing basis, the Company evaluates its estimates, including those related to revenue recognition, doubtful accounts, intangible assets, income taxes, valuation of equity instruments, accrued liabilities, contingencies and litigation. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ materially from these estimates.
	Cash
	The Company deposits its cash with major financial institutions and may at times exceed the federally insured limit of $250,000.  At September 30, 2014 cash exceeds the federally insured limit by $990,600.  The Company believes that the risk of loss is minimal. To date, the Company has not experienced any losses related to cash deposits with financial institutions.
	Derivative Liabilities
	The Company evaluates all of its agreements to determine if such instruments have derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the consolidated statements of operations. For stock-based derivative financial instruments, the Company uses a weighted average Black-Scholes option pricing model to value the derivative instruments at inception and on subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date. As of September 30, 2014, the Company’s only derivative financial instrument were a series of convertible notes with a “reset” and “dilutive issuance” clause within the notes relating to the conversion price from dilutive share issuance. See Notes 4 & 5.
	Fair Value of Financial Instruments
	ASC 825-10 (formerly Statement of Financial Accounting Standards (“SFAS”) 107, “Disclosures about Fair Value of Financial Instruments”) defines financial instruments and requires disclosure of the fair value of financial instruments held by the Company. The Company considers the carrying amount of cash, accounts receivable, other receivables, accounts payable and accrued liabilities, to approximate their fair values because of the short period of time between the origination of such instruments and their expected realization.
	The Company also analyzes all financial instruments with features of both liabilities and equity under ASC 480-10 (formerly SFAS 150, “Accounting for Certain Financial Instruments with Characteristics of Both Liabilities and Equity”), ASC 815-10 (formerly SFAS 133, “Accounting for Derivative Instruments and Hedging Activities”) and ASC 815-40 (formerly EITF 00-19, “Accounting for Derivative Financial Instruments Indexed to, and Potentially Settled in, a Company’s Own Stock”).
	The Company adopted ASC 820-10 (formerly SFAS 157, “Fair Value Measurements”) on January 1, 2008. ASC 820-10 defines fair value, establishes a three-level valuation hierarchy for disclosures of fair value measurement and enhances disclosure requirements for fair value measures. The three levels are defined as follows:
		⋅	Level 1 inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets;
		⋅	Level 2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the assets or liability, either directly or indirectly, for substantially the full term of the financial instruments; and
		⋅	Level 3 inputs to the valuation methodology are unobservable and significant to the fair value.
	The Company used Level 2 inputs for its valuation methodology for the conversion option liability in determining the fair value using the Black-Scholes option-pricing model with the following assumption inputs:
			September 30, 2014
	Annual dividend yield		-
	Expected life (years)		0.5
	Risk-free interest rate		0.03	%
	Expected volatility		55	%
			Carrying Value		Fair Value Measurements at
			As of		September 30, 2014
			September 30,		Using Fair Value Hierarchy
			2014		Level 1		Level 2		Level 3
	Liabilities
	Secured Convertible Debt		$	1,475,800		-	$	1,650,000		-
	Conversion option liability			153,100				153,100
	Total		$	1,628,900	$	-	$	1,803,100	$	-
	For the years ended September 30, 2014 and 2013, the Company had $153,100 and $0 derivative liabilities respectively. For the fiscal year ending September 30, 2014 and 2013, the Company had a change in fair valuation thereon of $26,100 and $0 respectively.  As at September 30, 2014, the Company did not identify any other assets or liabilities that are required to be presented on the balance sheet at fair value in accordance with ASC 825-10
	Accounts Receivable
	The Company estimates the collectability of customer receivables on an ongoing basis by reviewing past-due invoices and assessing the current creditworthiness of each customer.  Allowances are provided for specific receivables deemed to be at risk for collection which as of September 30, 2014 and 2013 are $1,200 and $5,900 respectively.
	Furniture and Equipment
	Furniture and Equipment, which are recorded at cost, consist of office furniture and equipment and are depreciated over their estimated useful life on a straight-line basis.  The useful life of these assets is estimated to be between three and five years.  Depreciation for the years ended September 30, 2014 and 2013 was $10,300 and $13,000 respectively.  Accumulated depreciation at September 30, 2014 and 2013 was $75,000 and $64,800, respectively.
	Offering Costs
	The Company applies ASC 505-10, “Costs of an Equity Transaction,” for recognition of offering costs. In accordance with ASC 505-10, the Company treats incremental direct costs incurred to issue shares classified as equity, as a reduction of the proceeds. Direct costs incurred before shares classified as equity are issued are classified as an asset until the stock is issued. Indirect costs such as management salaries or other general and administrative expenses and deferred costs of an aborted offering are expensed.
	Long-Lived Assets
	As required by ASC 350-30 (formerly SFAS No. 144, Accounting for the Impairment or Disposal of Long-Lived Assets), the Company reviews the carrying value of its long-lived assets whenever events or changes in circumstances indicate that the historical cost-carrying value of an asset may no longer be appropriate. The Company assesses recoverability of the carrying value of the asset by estimating the future net cash flows expected to result from the asset, including eventual disposition. If the future net cash flows are less than the carrying value of the asset, an impairment loss is recorded equal to the difference between the asset’s carrying value and fair value. No impairment loss was recorded for the years ended September 30, 2014 and 2013.
	The Company adopted Accounting standards update (“ASU”) 2012-02, Intangibles—Goodwill and Other (Topic 350): Testing Indefinite-Lived Intangible Assets for Impairment. The new guidance is intended to reduce the complexity and costs of the annual impairment test for indefinite-lived intangible assets by allowing companies to make a qualitative evaluation about the likelihood of impairment to determine whether it should perform a quantitative impairment test.
	Accounts Payable
	Accounts payable consists of trade payables of which $501,600 are for legal services. As of September 2014 we had accounts payable write-backs of $44,000 for long held-debts which have been in dispute and there has been no collection activity for over four years.
	Between November 11, 2013, and December 20, 2013, the Company issued an aggregate of 1,446,380 shares of its Common Stock, as full and complete settlement of trade debt totaling an aggregate of $1,466,800 owed to two creditors who are also accredited investors. The fair market value of the shares that were issued in these transactions was determined to be $0.25 per share. The excess value of $1,105,200 over the fair market value of the issued shares was booked to Other Income (Expense) as a gain on extinguishment of debt.
	Deferred Revenue
	Deferred revenue represents revenue collected but not earned as of September 30, 2014. This represents a philanthropic grant for the payment of PEER Reports ordered for the Walter Reed clinical trial during calendar 2014, which are otherwise not paid for by Walter Reed or Fort Belvoir. These deferred revenue grant funds as of September 30, 2014, are $45,900. As of September 30, 2013 there was no deferred revenue balance.
	Revenues
	The Company recognizes revenue on services, being the delivery of PEER Reports to medical providers, in accordance with the Financial Accounting Standards Board (“FASB”) ASC No. 605, “Revenue Recognition.”  In all cases, revenue is recognized when we have persuasive evidence of an arrangement, a determinable fee, when collection is considered to be reasonable assured and the services are delivered.
	Research and Development Expenses
	The Company charges all research and development expenses to operations as incurred.
	Advertising Expenses
	The Company charges all advertising expenses to operations as incurred. For the years ended September 30, 2014 and 2013 advertising expenses were $3,100 and $14,400 respectively.
	Stock-Based Compensation
	The Company has adopted ASC 718-20 (formerly SFAS No. 123R, Share-Based Payment - revised 2004) and related interpretations which establish the accounting for equity instruments exchanged for employee services. Under ASC 718-20, share-based compensation cost to option grantee, being employees, directors and consultants, and is measured at the grant date based on the calculated fair value of the award (see Note 5 for further discussion on valuations). The expense is recognized over the option grantees’ requisite service period, generally the vesting period of the award.
	Inducement to Convert Debt
	According to ASC 470-20-55, when a convertible debt instrument is converted to equity pursuant to an inducement offer, the debtor recognizes an expense equal to the fair value of all securities and other consideration transferred in the transaction in excess of the fair value of securities issuable pursuant to the original conversion terms. The fair value of the securities or other consideration is measured as of the date the inducement offer is accepted by the convertible debt holder.
	As an inducement to convert debt, the Company offered to all holders of $1 per share convertible notes (“$1 Notes”) an opportunity to convert that debt, and associated accrued interest, at $0.25 per share for a limited 60 day period with the proviso that 100% of the holders of the $1 Notes agreed to the conversion terms. All holders’ of $1 Notes agreed to convert and the transaction closed on August 12, 2013.
	Fair value of debt conversion on August 12, 2013
	Based on the volume of shares traded on the open market, during the period April 1, 2013 through to August 12, 2013, the date of the conversion of all $1 Notes, management judged that the Company’s stock was not actively traded as only $277,636 worth of stock was traded on 42 of 95 trading days during this period at prices ranging from $0.41 to $2.50. There was a contemporaneous transaction whereby shares corresponding to $827,500 of a $2.0 million private placement of common stock purchased at a price of $0.25 per share by accredited third party investors. Given the low volume of stock that was traded, compared to the volume of the private placement of common stock, management’s judgment was that the pricing of the private placement of common stock at $0.25 per share represented a better determinant of fair value of the Company’s common stock upon the conversion of debt on August 12, 2013.
	As the original conversion terms of the notes were at $1 into one share of common stock with a fair value of $0.25, consequently, the three additional shares offered on conversion at $0.25 each represent the inducement to convert.
	Income Taxes
	The Company accounts for income taxes under the asset and liability method.  Deferred tax assets and liabilities are recognized for future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases.  Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which the temporary differences are expected to be recovered or settled.  The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.  Valuation allowances are recorded, when necessary, to reduce deferred tax assets to the amount expected to be realized.
	As a result of the implementation of certain provisions of ASC 740,  Income  Taxes, (formerly FIN 48,  Accounting for Uncertainty in Income Taxes – An Interpretation of FASB Statement No. 109),  (“ASC 740”), which clarifies the accounting and disclosure for uncertainty in tax positions, as defined. ASC 740 seeks to reduce the diversity in practice associated with certain aspects of the recognition and measurement related to accounting for income taxes.  The Company adopted the provisions of ASC 740 and have analyzed filing positions in each of the federal and state jurisdictions where required to file income tax returns, as well as all open tax years in these jurisdictions.  We have identified the U.S. federal and California as our "major" tax jurisdictions.  Generally, we remain subject to Internal Revenue Service examination of our 2008 through 2012 U.S. federal income tax returns, and remain subject to California Franchise Tax Board examination of our 2008 through 2012 California Franchise Tax Returns.  However, we have certain tax attribute carryforwards which will remain subject to review and adjustment by the relevant tax authorities until the statute of limitations closes with respect to the year in which such attributes are utilized.
We believe that our income tax filing positions and deductions will be sustained on audit and do not anticipate any adjustments that will result in a material change to our financial position.  Therefore, no reserves for uncertain income tax positions have been recorded pursuant to ASC 740.  In addition, we did not record a cumulative effect adjustment related to the adoption of ASC 740.  Our policy for recording interest and penalties associated with income-based tax audits is to record such items as a component of income taxes.
Comprehensive Income (Loss)
ASC 220-10 (formerly, SFAS No. 130, Reporting Comprehensive Income), requires disclosure of all components of comprehensive income (loss) on an annual and interim basis.  Comprehensive income (loss) is defined as the change in equity of a business enterprise during a period from transactions and other events and circumstances from non-owner sources.  The Company’s comprehensive income (loss) is the same as its reported net income (loss) for the years ended September 30, 2014 and 2013.
Earnings (Loss) per Share
The Company has adopted GAAP regarding earnings (loss) per share, which requires presentation of basic and diluted earnings (loss) per share in conjunction with the disclosure of the methodology used in computing such earnings (loss) per share.
Basic earnings (loss) per share are computed by dividing income (loss) available to common stockholders by the weighted average common shares outstanding during the period. Diluted earnings (loss) per share takes into account the potential dilution that could occur if securities or other contracts to issue Common Stock were exercised and converted into Common Stock.
Recent Accounting Pronouncements
Apart from the below-mentioned recent accounting pronouncements, there are no new accounting pronouncements that are currently applicable to the Company.
In August, 2014, the FASB has issued Accounting Standards Update (ASU) No. 2014-15, Presentation of Financial Statements—Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern. ASU 2014-15 is intended to define management’s responsibility to evaluate whether there is substantial doubt about an organization’s ability to continue as a going concern and to provide related footnote disclosures. The Company does not expect the adoption of the standard update to have a material impact on its consolidated financial position or results of operations.
In August 2014, the FASB issued Accounting Standards Update (ASU) No. 2014-13, Consolidation (Topic 810): Measuring the Financial Assets and the Financial Liabilities of a Consolidated Collateralized Financing Entity. The amendments in this ASU will apply to a reporting entity that is required to consolidate a collateralized financing entity under the Variable Interest Entities guidance when: (1) the reporting entity measures all of the financial assets and the financial liabilities of that consolidated collateralized financing entity at fair value in the consolidated financial statements based on other Codification Topics; and (2) the changes in the fair values of those financial assets and financial liabilities are reflected in earnings. The Company does not expect the adoption of the standard update to have a material impact on its consolidated financial position or results of operations.
In June 2014, the FASB issued ASU No. 2014-12, Compensation – Stock Compensation (Topic 718): Accounting for Share-Based Payments When the Terms of an Award Provide That a Performance Target Could Be Achieved after the Requisite Service Period. The amendments in the ASU require that a performance target that affects vesting and that could be achieved after the requisite service period be treated as a performance condition. A reporting entity should apply existing guidance in Topic 718, Compensation – Stock Compensation, as it relates to awards with performance conditions that affect vesting to account for such awards. The performance target should not be reflected in estimating the grant-date fair value of the award. Compensation cost should be recognized in the period in which it becomes probable that the performance target will be achieved and should represent the compensation cost attributable to the period(s) for which the requisite service has already been rendered. The Company does not expect the adoption of the standard update to have a material impact on its consolidated financial position or results of operations.
In April 2014, the FASB issued ASU No. 2014-08, Presentation of Financial Statements (Topic 205) and Property, Plant, and Equipment (Topic 360) — Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity. The amendments in ASU 2014-08 change the criteria for reporting discontinued operations while enhancing disclosures in this area. Under the new guidance, only disposals representing a strategic shift in operations should be presented as discontinued operations. Those strategic shifts should have a major effect on the organization’s operations and financial results. In addition, the new guidance requires expanded disclosures about discontinued operations. The Company does not expect the adoption of the standard update to have a material impact on its consolidated financial position or results of operations.

DISCONTINUED_OPERATIONS

DISCONTINUED OPERATIONS	12 Months Ended
	Sep. 30, 2014
Discontinued Operations and Disposal Groups [Abstract]
Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]		3	DISCONTINUED OPERATIONS
	On September 30, 2012 the Company discontinued its Clinical Services Operation at its wholly-owned subsidiary Neuro Therapy Clinic, Inc. (“NTC”), because the operation had persistent losses which could no longer be supported by the Company. Furthermore, the Company chose to focus its limited cash resources to conduct its clinical trial at Walter Reed.
	As of September 30, 2012 the staff of NTC had departed and the premises were vacated. Prior to the clinic’s closure all patients were sent letters informing them where they could continue their treatment with their usual provider. Two of NTC’s providers joined a nearby psychiatric clinic operated by Compass Health Systems (“Compass”). NTC executed a business associate agreement with Compass to allow the confidential sharing of patient information and to enable the providers to continue to treat their patients. All revenues and operating expenses under this management agreement would belong to Compass. All NTC assets and liabilities incurred prior to October 1, 2012 would remain with the Company.
	Summary Financial Data of Discontinued Operations:
	Revenues, income before income taxes and net loss of NTC which are included in discontinued operations are as follows:
			2014		2013
	Neuro-Therapy Clinic
	Revenues		$	-	$	-
	Expenses			2,700		19,400
	Operating Loss before taxes		$	-2,700	$	-19,400
	Taxes			-		-
	Net Loss		$	-2,700	$	-19,400
	The assets and liabilities of NTC are as follows:
			2014		2013
	ASSETS:
	Assets of Discontinued Operations		$	-	$	-
	LIABILITIES:
	Accounts Payable		$	86,600	$	88,500
	Accrued Payroll Liabilities			90,600		130,000
	Note Payable (see Note 10)			-		50,000
	Liabilities of Discontinued Operations		$	177,200	$	268,500

CONVERTIBLE_DEBT_AND_EQUITY_FI

CONVERTIBLE DEBT AND EQUITY FINANCINGS	12 Months Ended
	Sep. 30, 2014
Debt Disclosure [Abstract]
Debt Disclosure [Text Block]		4	CONVERTIBLE DEBT AND EQUITY FINANCINGS
	During 2010, 2011 and 2012, we had entered into five private placement financings of convertible debt summarized below. As of October 1, 2012, the combined outstanding balance of all the convertible debt was $8,012,000 with debt discount balance of $824,400. By September 30, 2013, all convertible debt, and interest thereon, had been converted into 76,448,279 shares of Common Stock. During the year ended September 30, 2013, the Company amortized $662,300 of the debt discount. As all the debt had been converted in fiscal year 2013, no debt discount was amortized during the year ended September 30, 2014 related to these notes.
	Effective October 24, 2012, pursuant the Amended & Restated Consent, Note Amendment and Warrant Forfeiture Agreement the conversion price of the October 2010 Notes, the January 2011 Notes, October 2011 Notes and the February 2012 Note (the “$1 Notes) was amended to $1 per share and all warrants that were originally issued along with these notes were forfeited.
	Effective August 12, 2013, pursuant to the offer letter to induce the conversion of debt and the Omnibus Note Amendment Agreement (the “Conversion Agreement”), all the $1 Notes, with the exception of the notes held by various entities controlled by SAIL Capital Partners, were converted to stock at a price of $0.25 per share.
		1)	The October 2010 Notes: These were approved by the Company’s Board on September 26, 2010, for the issuance of approximately $3 million in secured convertible promissory notes, bearing interest at 9% per annum, to be issued by January 31, 2011, and included the exchange of bridge notes, with accrued interest, issued, to two directors. The October 2010 Notes in the aggregate principal amount of $3,023,900 and warrants to purchase 503,998 (ratchet and reverse split adjusted) shares of common stock were issued by November 12, 2010. A $250,000 note plus $53,300 of interest thereon which was held by SAIL Venture Partners was converted on January 31, 2013, into 303,313 shares of common stock at $1 per share. The remaining $2,773,900 notes plus $712,000 of interest thereon were converted into 13,943,539 shares of common stock pursuant the Conversion Agreement. The combined conversions of the October 2010 Notes of $3,023,900 of principal plus $765,259 of interest converted into 14,246,852 shares.
		2)	The January 2011 Notes: On November 23, 2010, the Company’s Board approved an approximate aggregate offering amount of $5 million in subordinated convertible promissory notes, bearing interest at 9% per annum, to be issued by July 31, 2011. From January 20, 2011 through April 25, 2011, the Company issued January 2011 Notes in an aggregate principal amount of $2,500,000 and warrants to purchase 416,674 (ratchet and reverse split adjusted) shares of common stock. Six notes in the aggregate amount of $1,000,000 plus $166,500 of interest thereon, which were held by various SAIL entities were converted on January 31, 2013, into 1,166,503 shares of common stock at $1 per share. The remaining $1,500,000 notes plus $334,100 of interest thereon were converted into 7,336,500 shares of common stock pursuant to the Conversion Agreement. The combined conversions of the January 2011 Notes of $2,500,000 of principal plus $500,600 of interest converted into 8,503,003 shares.
		3)	The October 2011 Notes: On September 30, 2011, the Company’s Board approved an approximate aggregate offering amount of $2 million in subordinated convertible promissory notes, bearing interest at 9% per annum, to be issued by April 1, 2012. From October 18, 2011 through January 31, 2012, the Company issued October 2011 Notes in an aggregate principal amount of $2,000,000 and warrants to purchase 666,673 (ratchet and reverse split adjusted) shares of common stock. The $2,000,000 notes plus 301,400 of interest thereon were converted into 9,205,680 shares of common stock pursuant to the Conversion Agreement.
	During the fiscal year ended September 30, 2013, the Company amortized $277,100 of the debt discount. There was no amortization in fiscal year 2014.
		4)	The February 2012 Note: On February 29, 2012, the Company raised $90,000 through the sale of a subordinated unsecured February 2011 Note, bearing interest at 9% per annum, and warrant to purchase 30,000 (ratchet and reverse split adjusted) shares of common stock. The $90,000 note plus $11,900 of interest thereon was converted into 407,700 shares of common stock pursuant to the Conversion Agreement.
	During the fiscal years ended September 30, 2013, the Company amortized $15,000 of the debt discount. There was no amortization in fiscal year 2014.
		5)	The October 2012 Notes: From August 17, 2012 through September 30, 2012, the Company issued five August 2012 Bridge Notes (these August 2012 Notes were subsequently replaced by October 2012 Notes) in an aggregate principal amount of $400,000 as part of a $2 million bridge financing. No warrants were issued in conjunction with these notes. Furthermore $1,900 of these notes were converted into 40,000 shares of common stock prior to September 30, 2012 leaving an aggregate net $398,100 of convertible promissory August 2012 Bridge Notes outstanding.
	On October 19, 2012 the August 2012 Bridge Financing Purchase Agreement in connection with the August 2012 Bridge Notes was amended and restated (the “Amended and Restated Bridge Financing Purchase Agreement”) thereby extending the period for closing the sale of August 2012 Bridge Notes from October 15, 2012 to November 30, 2012. Additionally, the revised notes (“October 2012 Notes”) eliminated the mandatory conversion provision (upon a subsequent equity financing) included in the August 2012 Bridge Notes. Otherwise the October 2012 Bridge Notes had substantially the same terms as the August 2012 Notes.
	The Amended and Restated Bridge Financing Purchase Agreement provided for the issuance and sale of Bridge Notes in the aggregate principal amount of up to $2,000,000, in one or multiple closings to occur no later than November 30, 2012. Additionally this amended and restated agreement also provided for the reissuance and replacement of the five August 2012 Notes with the revised October 2012 Notes.
	Between January 31, 2013, and September 30, 2013, all $1,998,200 of October 2012 Notes and $81,800 of interest thereon were converted into 44,085,044 shares of common stock at $0.4718 per share.
	As of September 30, 2014 and 2013, no October 2012 Notes were outstanding. During the fiscal years ended September 30, 2014 and 2013, the Company amortized $0 and $370,200 of the debt discount respectively.
	According to ASC 470-20-55, when a convertible debt instrument is converted to equity pursuant to an inducement offer, the debtor recognizes an expense equal to the fair value of all securities and other consideration transferred in the transaction in excess of the fair value of securities issuable pursuant to the original conversion terms. The fair value of the securities or other consideration is measured as of the date the inducement offer is accepted by the convertible debt holder. In order to induce the holders of the October 2010 Notes, the January 2011 Notes, the October 2011 Notes and the February 2011 Note for which the original conversion terms were at $1 per share of common stock, the Board approved a 60-day period whereby the holders of these $1 notes could convert their notes at $0.25 per share of common stock, provided that 100% of these note holders agreed to convert. Effective August 12, 2013, all $1 note holders agreed to convert $7,723,300 of debt and interest thereon into 30,893,419 shares of common stock at $0.25 per share. Consequently, the fair value of three of the four shares converted per $1.00 in this transaction were determined to be an inducement to convert and were valued at an aggregate amount of $5,792,500; this amount was expensed as an Inducement to Convert on August 12, 2013.
	The September 2014 Notes: Starting September 22, 2014, through September 26, 2014, the Company entered into a new Note Purchase Agreement (the “Note Purchase Agreement”) in connection with a bridge financing, with seven accredited investors, including lead investor RSJ Private Equity (“RSJ PE”).  Pursuant to the Note Purchase Agreement, the Company issued seven secured convertible promissory notes (each, a “September 2014 Note”) in the aggregate principal amount of $1.65 million. Of this amount, RSJ PE purchased a September 2014 Note for $750,000. The September 2014 Notes were also purchased by the following affiliates of the Company or entities under their control: The Tierney Family Trust, of which the Company’s Chairman of the Board, Thomas Tierney, is a trustee, purchased a September 2014 Note for $200,000; the Company’s Director, John Pappajohn, purchased a September 2014 Note for $200,000; and Oman Ventures, of which Mark Oman, a greater than 5% stockholder of the Company, is the President, purchased a September 2014 Note for $200,000.
				As of September 30, 2014
								Carrying
				Balance		Discount		Value
	Note Type and Investor		Due Date	($)		($)		($)
	Senior Secured 5% Notes Convertible at $0.25
	(the “September 2014 Notes”)
	RSJ Private Equity		3/21/16	$	750,000	$	-67,900	$	682,100
	4 Accredited Investors		3/21/16		300,000		-28,900		271,100
	John Pappajohn		3/21/16		200,000		-25,800		174,200
	Tierney Family Trust		3/21/16		200,000		-25,800		174,200
	Oman Ventures		3/21/16		200,000		-25,800		174,200
	Total Secured Convertible Promissory (September 2014) Notes			$	1,650,000	$	-174,200	$	1,475,800
	The Note Purchase Agreement provides for the issuance and sale of September 2014 Notes in the aggregate principal amount of up to $2.5 million, in one or more closings to occur over a six-month period beginning September 22, 2014. The Note Purchase Agreement also provides that the Company and the holders of the September 2014 Notes enter into a registration rights agreement covering the registration of the resale of the shares of the Company’s Common Stock underlying the September 2014 Notes.
	The September 2014 Notes mature on March 21, 2016, which is eighteen months from the date of first issuance (subject to earlier conversion or prepayment), earn interest at a rate of 5% per annum with interest payable at maturity, are convertible into shares of Common Stock (i) automatically upon the closing of a qualified offering of no less than $5 million at a conversion price equal to the lesser of $0.25 or 70% of the lowest cost of Common Stock offered by the Company, but in no event less than $0.10 per share or (ii) voluntarily within 15 days of maturity at the lesser of a conversion price equal to $0.25 or the lowest cost of Common Stock offered by the Company, but in no event less than $0.10 per share. No September 2014 Note may be prepaid without the prior written consent of the holder of such Note. The September 2014 Notes are secured by a security interest in the Company’s intellectual property, as detailed in a security agreement. Upon a change of control of the Company, the holder of a September 2014 Note will have the option to have the Note repaid with a premium equal to 50% of the outstanding principal.

DERIVATIVE_LIABILITIES

DERIVATIVE LIABILITIES	12 Months Ended
	Sep. 30, 2014
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivatives and Fair Value [Text Block]		5	DERIVATIVE LIABILITIES
	Effective November 28, 2012, the Company, together with the majority of the note holders of each tranche of notes issued in October 2010, January 2011, October 2011 and February 2011 (the “$1 Notes”) (see Note 4 above), agreed to amend the Notes, pursuant to the terms of the Amended and Restated Consent, Note Amendment and Warrant Forfeiture Agreement (the “Note Agreement”), dated as of October 24, 2012, to (a) extend the maturity date of the Notes to October 1, 2013, (b) set the conversion price at $1.00, subject to adjustment as provided in the Notes and (c) remove full-ratchet anti-dilution protection. In addition, the holders forfeited the warrants they received in connection with the issuance of the Notes, and consented to the 2012 Bridge Financing, the issuance of the October 2012 Notes and to the subordination of the Notes to the October 2012 Notes. Both the convertible notes and warrants had contained ratchet provisions, which under ASC 815 required bifurcation of the conversion feature and warrants for derivative liability treatment. The interest rate on all the Notes remained unchanged at 9% per annum. Using the Black Scholes model, each tranche of Notes, as of November 28, 2012 were valued and compared with the value of the Notes on the prior day with their original maturity dates.  The difference of the two valuation calculations of $556,300 was booked to Other Expenses as a gain on extinguishment of debt. Since November 28, 2012, with the elimination of the warrants and the removal of the ratchet in the convertible debt instruments, which have subsequently been converted into equity, the Company had no derivative liabilities at September 30, 2013.
	The Black-Scholes option-pricing model with the following assumption inputs:
			November 27, 2012				November 28, 2012
	Annual dividend yield			-				-
	Expected life (years)			3.5				3.5
	Risk-free interest rate			0.36	%			0.35	%
	Expected volatility			113.52	%			113.62	%
	During September 2014, the Company raised $1.65 million in a private placement of secured convertible debt at $0.25 per share of Common Stock. This debt instrument also has a ratchet whereby the conversion price of $0.25 per share can be reduced to a minimum of $0.10 per share (see Note 4). The inclusion of this ratchet requires the determination of the fair market carrying value. At issuance, the note discount and derivative liability using the Black-Scholes model was $179,200 and at September 30, 2014, upon revaluation, the derivative liability value was reduced to $153,100 with a resultant gain of $26,100 from derivative liabilities being booked to other income in the income statement.
	The Black-Scholes option-pricing model with the following assumption inputs:
			September 22 to 29, 2014		September 30, 2014
	Annual dividend yield				-
	Expected life (years)		0.5		0.5
	Risk-free interest rate		0.03% - 0.05	%	0.03	%
	Expected volatility		55	%	55	%

STOCKHOLDERS_DEFICIT

STOCKHOLDERS' DEFICIT	12 Months Ended
	Sep. 30, 2014
Stockholders' Equity Note [Abstract]
Stockholders' Equity Note Disclosure [Text Block]		6	STOCKHOLDERS’ DEFICIT
	Common and Preferred Stock
	As of September 30, 2014, the Company is authorized to issue 195,000,000 shares of stock of which 180,000,000 are Common Stock at par value of $0.001 per share; the remaining 15,000,000 shares, with a par value of $0.001 per shares are blank-check preferred stock which the Board are expressly authorized to provide, for one or more series of preferred stock and, with respect to each such series, to fix the number of shares constituting such series and the designation of such series, the voting powers, if any, of the shares of such series, and the preferences and relative, participating, optional or other special rights, if any, and any qualifications, limitations or restrictions thereof, of the shares of such series. The powers, preferences and relative, participating, optional and other special rights of each series of preferred stock, and the qualifications, limitations or restrictions thereof, if any, may differ from those of any and all other series at any time outstanding.
	As of September 30, 2014, 101,667,409 shares of Common Stock were issued and outstanding. No shares of preferred stock were issued or outstanding.
	As a condition of the November 28, 2012 closing of the 2012 Bridge Financing, the Company also entered into Employment Compensation Forfeiture and Exchange Agreements (the “Forfeiture and Exchange Agreements”) with three of its executive officers. Pursuant to these agreements, the executives agreed to waive receipt of and release the Company from the payment in aggregate of $165,700 representing 50% of their accrued and unpaid salaries in consideration for which the Company agreed to issue to such executives an aggregate 165,666 shares of its Common Stock. The per share value of the Common Stock $0.04718 per share, the same as the conversion price of the October 2012 Notes. (Refer to Note 8. Related Party Transactions)
	From January 18, 2013, through September 30, 2013, the $1,998,200 of holders’ of October 2012 Notes converted all their debt and interest thereon into 44,085,044 shares of Common Stock, at a conversion price of $0.04718 per share. (Refer to Note 8. Related Party Transactions)
	On January 31, 2013, SAIL Capital Partners converted all their notes convertible at $1.00 in the aggregate principal amount of $1,250,000 and $219,800 of interest thereon into 1,469,816 shares of Common Stock. (Refer to Note 4. Convertible Debt and Equity Financings and Note 8. Related Party Transactions)
	From February 22, 2013, through September 12, 2013, 39 accredited investors purchased an aggregate of 12,180,000 shares of Common Stock at a price of $0.25 per share in private placement transactions. The Company received gross aggregate cash proceeds of $3,045,000. (Refer to Note 8. Related Party Transactions)
	On March 26, 2013, the Board resolved to amend the Company’s Charter in order to:
		1)	increase the number of shares of Common Stock authorized for issuance under the Charter from 100,000,000 to 150,000,000; and
		2)	create one or more series of preferred stock, par value $0.001 per share, and authorize 15,000,000 shares of such preferred stock for issuance.
	This amendment to the Charter was approved by more than 80% of the stockholders eligible to vote at the annual meeting of stockholders which was held on May 23, 2013.
	On August 12, 2013, pursuant to an offer to all holders of debt convertible into Common Stock at $1.00 per share, all holders agreed to convert $7,723,300 of convertible debt, which included $1,359,400 interest thereon, into 30,893,419 shares of Common Stock, at a per share price of $0.25. (Refer to Note 6. Related Party Transactions)
	Below is a summary of all promissory notes conversions:
			Shares of
			Common			Conversion		Conversion			Principal
	Conversion of Notes		Stock			Date		Price			Amount			Interest			Total
	Fiscal Year 2012
	October 2012 Notes:
	Unsecured convertible notes			40,000		9/19/12		$	0.04718		$	1,800		$	100		$	1,900
	Fiscal Year 2013
	October 2010 Notes: Senior			303,313		1/31/13		$	1		$	250,000		$	53,300		$	303,300
	subordinated convertible notes			13,943,539		8/12/13		$	0.25			2,773,900			712,000			3,485,900
	Total October 2010 Notes:			14,246,852							$	3,023,900		$	765,300		$	3,789,200
	January 2011 Notes:			1,166,503		1/31/13		$	1		$	1,000,000		$	166,500		$	1,166,500
	Subordinated convertible notes			7,336,500		8/12/13		$	0.25			1,500,000			334,100			1,834,100
	Total January 2011 Notes:			8,503,003							$	2,500,000		$	500,600		$	3,000,600
	October 2011 Notes:
	Subordinated convertible notes			9,205,680		8/12/13		$	0.25		$	2,000,000		$	301,400		$	2,301,400
	February 2012 Notes:
	Unsecured convertible note			407,700		8/12/13		$	0.25		$	90,000		$	11,900		$	101,900
	October 2012 Notes:
	Unsecured convertible notes			44,085,044		01/18/13 through 09/30/13		$	0.04718		$	1,998,200		$	81,800		$	2,080,000
	Total of Notes Converted in Fiscal 2013			76,448,279							$	9,612,100		$	1,661,000		$	11,273,100
	Total of Notes Converted			76,488,279							$	9,613,900		$	1,661,100		$	11,275,000
	From August 30, 2013, through September 30, 2013, pursuant to a subscription agreement, 10 vendors converted an aggregate $502,100 of trade payables into 2,008,318 shares of Common Stock, par value $0.001, at a price for $0.25 per share. (Refer to Note 8. Related Party Transactions)
	From October 4, 2013, through February 14, 2014, 29 accredited investors purchased an aggregate of 5,900,000 shares of Common Stock, at a price of $0.25 per share pursuant to private placements. The Company received gross aggregate cash proceeds of $1,475,000. (Refer to Note 8. Related Party Transactions)
	Between November 11, 2013, and December 20, 2013, the Company issued an aggregate of 1,446,380 shares of its Common Stock valued at $361,500, as full and complete settlement of trade payables totaling an aggregate $1,466,800 owed to two creditors who are also accredited investors. As a result of this transaction the Company recorded a gain on extinguishment of debt of $1,105,200.
	On March 21, 2014, the Board resolved to amend the Company’s Charter in order to further increase the number of shares of Common Stock authorized for issuance under the Charter from 150,000,000 to 180,000,000. This amendment to the Charter was approved by more than 65% of the stockholders eligible to vote at the annual meeting of stockholders held on May 13, 2014.
	From July 8, 2014 through July 23, 2014, 8 accredited investors purchased an aggregate of 1,040,000 shares of Common Stock, at a price of $0.25 per share pursuant to private placements. The Company received gross aggregate cash proceeds of $260,000. (Refer to Note 8. Related Party Transactions)
	On January 29, 2014 and June 20, 2014, placement agent warrants to purchase in aggregate 608,309 shares of Common Stock with a price of $0.04718 per share were exercised on a net basis resulting in the issuance of 564,467 shares of Common Stock.
	Stock-Option Plans
	On August 3, 2006, CNS California adopted the CNS California 2006 Stock Incentive Plan (the “2006 Plan”). The 2006 Plan provides for the issuance of awards in the form of restricted shares, stock options (which may constitute incentive stock options (ISO) or non-statutory stock options (NSO), stock appreciation rights and stock unit grants to eligible employees, Directors and consultants and is administered by the Board. A total of 667,667 shares of stock were ultimately reserved for issuance under the 2006 Plan. As of September 30, 2014, 70,825 options were exercised and there were 501,924 options and 6,132 restricted shares outstanding under the amended 2006 Plan leaving 87,786 shares which will not be issued as the 2006 Plan has been frozen. The outstanding options have exercise prices to purchase shares of Common Stock ranging from $3.60 to $32.70.
	On March 22, 2012, our Board approved the CNS Response, Inc. 2012 Omnibus Incentive Compensation Plan (the “2012 Plan”), reserved 333,334 shares of stock for issuance and approved the grant of options to purchase 42,670 shares of Common Stock pursuant to such plan at an exercise price of $3.00 per share, including options to purchase 8,334 shares to each of our Directors Zachary McAdoo and Maurice DeWald.
	On December 10, 2012, the Board approved the amendment of the Company’s 2012 Omnibus Incentive Compensation Plan (the “2012 Plan”) to increase the shares authorized for issuance under the 2012 Plan from 333,334 shares to 5,500,000 shares and granted to each of its three existing members as well as to each Richard Turner, Robert Follman, Andrew Sassine and Thomas Tierney (collectively, the “New Board Members”) options to purchase 250,000 shares of its Common Stock pursuant to the 2012 Plan at an exercise price of $0.04718 per share. The options vest evenly over 36 months starting from the date of grant. The Board furthermore granted to each of the five former Directors who had departed the Board effective November 30, 2012, (George Carpenter, Henry Harbin, George Kallins, David Jones, and Maurice DeWald), options to purchase 25,000 shares of its Common Stock pursuant to the 2012 Plan at an exercise price of $0.04718 per share. These options to former Directors are fully vested. Finally, the Board granted to the Company’s executive officers options to purchase shares of its Common Stock pursuant to the 2012 Plan at an exercise price of $0.04718 per share as follows: George Carpenter 1,200,000 shares, Paul Buck 1,400,000 shares and Michael Darkoch 920,000 shares. These options vest in increments of 12.5% at the beginning of each quarter starting from the date of grant.
	Based on the volume of shares traded on the open market, during the period October 1, 2012 through to December 10, 2012, the date of the option grant, management judged that the Company’s stock was not actively traded as only $15,000 worth of stock was traded on 11 of 48 trading days during this period at prices ranging from $0.76 to $0.83. In a contemporaneous transaction, Senior Secured Convertible Notes (“October 2012 Notes”) with a conversion price of $0.04718 were purchased by accredited third party investors. Given the very low volume of stock which was not actively traded, compared to the volume of October 2012 Notes purchased, management’s judgment was that the pricing of the October 2012 Notes at $0.04718 represented a better determinant of fair value of the Company’s Common Stock on December 10, 2012.
	On January 14, 2013, the Board granted options to purchase 1,960,000 shares of Common Stock to members of staff and 1,600,000 share of Common Stock to key consultants. The options granted to staff vest evenly over 48 months starting on the date of grant. The options granted to consultants vest evenly over 36 months starting on the date of grant. All these options have an exercise price of $0.04718 per share.
	Based on the volume of shares traded on the open market, during the period October 1, 2012 through to January 14, 2013, the date of the option grant, management judged that the Company’s stock was not actively traded as only $36,700 worth of stock was traded on 21 of 50 trading days during this period at prices ranging from $0.49 to $2.50. There had been a recent transaction which closed on November 30, 2012 whereby $2 million of Senior Secured Convertible Notes (“October 2012 Notes”) with a conversion price of $0.04718 were purchased by accredited third party investors. Given the low volume of stock which was not actively traded when compared to the volume of October 2012 Notes purchased, management judged that the pricing of the October 2012 Notes at $0.04718 represented a better determinant of fair value of the Company’s Common Stock on January 14, 2013.
	On March 26, 2013, the Board approved the amendment of the Company’s 2012 Plan to increase the shares authorized for issuance under the 2012 Plan from 5,500,000 shares to 15,000,000 shares. The Board also granted options to purchase 250,000 shares of Common Stock to Thomas Tierney upon his election to be Chairman of the Board. These options granted to Mr. Tierney vest evenly over 36 months starting on the date of grant and have an exercise price of $0.25 per share.
	Based on the volume of shares traded on the open market, during the period January 1, 2013, through to March 26, 2013, the date of the option grant, management judged that the Company’s stock was not actively traded as only $283,400 worth of stock was traded on 22 of 58 trading days during this period at prices ranging from $0.46 to $0.83. There was a contemporaneous transaction whereby $695,000 worth of a $2.5 million private placement offering of Common Stock at a price of $0.25 per share were purchased by accredited third party investors. Given the low volume of stock which was not actively traded, compared to the volume of the private placement of Common Stock, management judged that the pricing of the private placement of Common Stock at $0.25 per share represented a better determinant of fair value of the Company’s Common Stock on March 26, 2013.
	The 2012 Plan, as amended, was approved by our stockholders at the 2013 annual meeting held on May 23, 2013.
	On October 8, 2013, the Board granted to the Company’s two executive officers and two senior managers (collectively, the “Managers”) options to purchase shares of its Common Stock pursuant to the 2012 Omnibus Incentive Compensation Plan, as amended (the “2012 Plan”), at an exercise price of $0.25 per share as follows: George Carpenter 435,000 shares, Paul Buck 470,000 shares, Stewart Navarre 385,000 shares and Brian MacDonald 310,000. These options vest pro-rata over 12 months starting from the date of grant. The four managers have agreed to forego a portion of their salaries in fiscal year 2014 as follows: George Carpenter $98,000, Paul Buck $106,500, Stewart Navarre $83,600 and Brian MacDonald $66,700. These executive officers and managers will be paid out of the salaries which were earned and accrued during fiscal year 2012 and fiscal year 2013. The accruals to be paid out are equivalent to the fiscal year 2014 salaries that each of the executive officers and managers agreed to forego in lieu of receiving options.
	On November 8, 2013, the Board granted 700,000 options to purchase shares of its Common Stock pursuant to the 2012 Plan, at an exercise price of $0.25 per share to select consultants and staff, excluding the managers. The staff options vest evenly over 48 months starting on the date of grant; consultant options vest evenly over 36 months starting on the date of grant.
	On July, 2014, the Board granted 425,000 options to purchase shares of its Common Stock pursuant to the 2012 Plan, at an exercise price of $0.26 per share to select consultants. These options vest evenly over 36 months starting on the date of grant.
	Based on the volume of shares traded on the open market, during the period July 1, 2013, through to November 8, 2013, which covers the both option grant dates of October 8, 2013, and November 8, 2013, management judged that the Company’s stock was not actively traded, due to the fact that only $180,000 worth of stock was traded on 51 of 93 trading days during this period at prices ranging from $0.30 to $1.74. There was a contemporaneous transaction whereby $2,047,500 worth of stock was purchased in a private placement offering of Common Stock at a price of $0.25 per share by accredited investors. Given the low volume of stock, which was not actively traded, compared to the volume of the private placement of Common Stock, management judged that the pricing of the private placement of Common Stock at $0.25 per share represented a better determinant of fair value of the Company’s Common Stock on the dates that the options were granted.
	As of September 30, 2014, 11,915,575 options are issued and outstanding under the 2012 Plan, none of which have been exercised and 3,084,425 remain available for issuance. The outstanding options have exercise prices to purchase shares of Common Stock ranging from $0.04718 to $0.25.
	The Company estimates the fair value of each option on the grant date using the Black-Scholes model.   The following assumptions were made in estimating the fair value:
			2014				2013
	Annual dividend yield			-				-
	Expected life (years)			5				5
	Risk-free interest rate			1.42% - 1.76	%			0.62% - 0.79	%
	Expected volatility			116% - 129	%			380% - 393	%
	Fair value of options granted		$	0.21			$	0.05 - 0.25
	Stock-based compensation expense is recognized over the employees’ or service provider’s requisite service period, generally the vesting period of the award. Stock-based compensation expense included in the accompanying statements of operations for the year ended September 30, 2014 and 2013 is as follows:
		For the fiscal year ended
		September 30,
		2014				2013
Cost of Neurometric Services revenues		$	5,100			$	10,600
Research			65,500				92,700
Product Development			249,700				113,300
Sales and marketing			87,700				155,500
General and administrative			600,700				885,200
Total		$	1,008,700			$	1,257,300
Total unrecognized compensation as of September 30, 2014 amounted to $360,300.
A summary of stock option activity is as follows:
	Number of				Weighted Average
		Shares			Exercise Price
Outstanding at September 30, 2012			546,746		$	17.08
Granted			9,205,000			0.05
Exercised			-			-
Forfeited			-2,152			14.1
Outstanding at September 30, 2013			9,749,594		$	1
Granted			2,725,000			0.25
Exercised			-			-
Forfeited			-57,095			12.67
Outstanding at September 30, 2014			12,417,499		$	0.84
Following is a summary of the status of options outstanding at September 30, 2014:
						Weighted			Weighted			Vested and			Weighted			Aggregate Intrinsic
						Average			Average			Exercisable at			Average			Value at $0.22 price
Exercise			Number			Contractual			Exercise			September			Remaining			per share at
Price			of Shares			Life			Price			30, 2014			Life (Years)			September 30, 2014
$	0.04718			8,920,300			10 years		$	0.04718			6,538,494			8.2		$	1,541,606
$	0.25			2,527,605			10 years			0.25			1,951,216			9			-
$	0.26			425,000			10 years			0.26			35,417			9.8			-
$	3			42,670			10 years			3			37,929			7.5			-
$	3.6			28,648			10 years			3.6			28,648			1.9			-
$	3.96			32,928			10 years			3.96			32,928			1.9			-
$	9			4,525			10 years			9			4,525			2.1			-
$	12			28,535			10 years			12			28,535			5.7			-
$	14.1			10,000			10 years			14.1			8,958			6.5			-
$	15.3			1,373			10 years			15.3			1,373			4			-
$	16.5			262,441			10 years			16.5			262,441			5.4			-
$	17.7			953			10 years			17.7			953			1.9			-
$	24			4,667			10 years			24			4,667			3.2			-
$	26.7			32,297			10 years			26.7			32,297			3			-
$	28.8			11,767			10 years			28.8			11,767			3.5			-
$	32.7			83,790			10 years			32.7			83,790			2.8			-
	Total			12,417,499					$	0.843			9,063,938			4.79		$	1,541,606
Warrants to Purchase Common Stock
The warrant activity for the period starting October 1, 2012, through September 30, 2014, is described as follows:
		Exercise
Warrants		Price				Issued, Surrendered or Expired in Connection With:
2,164,440		$				Warrants outstanding at October 1, 2012
-1,617,345			3			Warrants forfeited pursuant to the Amended and Restated Consent, Note Amendment and Warrant Forfeiture Agreement dated October 24, 2012
127,173			0.04718			These warrants were issued to Monarch Capital who acted as placement agents in raising $60,000 from one investor who purchased October 2012 Notes pursuant to the 2012 Bridge Note October Purchase Agreement.
519,288			0.04718			These warrants due to be issued to Tony Pullen who acted as placement agents in raising $350,000 from three investors who purchased October 2012 Notes pursuant to the 2012 Bridge Note October Purchase Agreement.
152,000			0.275			These warrants were issued to Monarch Capital who acted as placement agents in raising $380,000 from twelve accredited investors who purchased common stock, par value $0.001 per share, in private placement agreements dated February 20, 2013 and May 23, 2013.
100,000			0.25			These warrants were issued to D&D Securities Inc. in connection with the Company’s private offering to select accredited investors of shares of restricted common stock at a private of $0.25 per share, in a private placement agreement dated February 20, 2013.
52,000			0.275			These warrants were issued to Monarch Capital who acted as placement agents in raising $520,000 from five accredited investors who purchased common stock, par value $0.001 per share, in a private placement agreement dated May 23, 2013.
1,497,556		$	3.03			Warrants outstanding at September 30, 2013
120,000			0.275			Warrants issued to Monarch Capital who acted as placement agents in raising $300,000 from 11 accredited investors who purchased restricted common stock, par value $0.001 per share, in a private placement agreements dated October 2, 2013 and January 8, 2014.
32,200			0.25			Warrants issued to D&D Securities Inc. who acted as placement agents in raising $115,000 from three accredited investors who purchased restricted common stock, par value $0.001 per share, in a private placement agreement dated January 8, 2014.
-519,288			0.04718			Warrants exercised as of January 29, 2013.
-89,021			0.04718			Warrants exercised as of June 20, 2014.
-226,703			$9.00 to $9.90			Warrants expired
814,744		$	3.07			Warrants outstanding at September 30, 2014
At September 30, 2014, there were warrants outstanding to purchase 814,744 shares of the Company’s common stock. The exercise price of the outstanding warrants range from $0.04718 to $9.90 with a weighted average exercise price of $3.07.  The warrants expire at various times starting 2014 through 2019.

INCOME_TAXES

INCOME TAXES	12 Months Ended
	Sep. 30, 2014
Income Tax Disclosure [Abstract]
Income Tax Disclosure [Text Block]		7	INCOME TAXES
	The Company accounts for income taxes under the liability method. Deferred tax assets and liabilities are determined based on differences between financial reporting and tax bases of assets and liabilities, and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company provides a valuation allowance to reduce the Company’s deferred tax assets to their estimated realizable value.
	Reconciliations of the provision (benefit) for income taxes to the amount compiled by applying the statutory federal income tax rate to profit (loss) before income taxes is as follows for each of the fiscal years ended September 30:
		2014				2013
	Federal income tax (benefit) at statutory rates			-34	%			-34	%
	Stock-based compensation			-0.2	%			3	%
	Nondeductible interest expense			-				4	%
	Extinguishment of debt			1.5	%			-2	%
	Change in valuation allowance			-5	%			3	%
	True-ups and other adjustments			-26.9	%			-
	State tax benefit			-3.4	%			9	%
	Inducement to convert			-				17	%
	Temporary differences between the financial statement carrying amounts and bases of assets and liabilities that give rise to significant portions of deferred taxes relate to the following at September 30, 2014 and 2013:
			2014			2013
	Deferred income tax assets:
	Net operating loss carryforward		$	13,083,200		$	15,370,600
	Deferred interest, consulting and compensation liabilities			1,529,800			1,168,300
	Amortization			-			2,900
	Deferred income tax assets – other			5,800			4,300
				14,618,800			16,546,100
	Deferred income tax liabilities—other			-1,600			-
	Deferred income tax asset—net before valuation allowance			14,617,200			16,546,100
	Valuation allowance			-14,617,200			-16,546,100
	Deferred income tax asset—net		$	-		$	-
	Current and non-current deferred taxes have been recorded on a net basis in the accompanying balance sheet. As of September 30, 2014, the Company had Federal net operating loss carryforwards of approximately $31.6 million and State net operating loss carryforwards of approximately $51.0 million. Both the Federal and State net operating loss carryforwards will begin to expire in 2034. Our ability to utilize net operating loss carryforwards may be limited in the event that a change in ownership, as defined in the Internal Revenue Code, occurs in the future. The Company has placed a valuation allowance against the deferred tax assets in excess of deferred tax liabilities due to the uncertainty surrounding the realization of such excess tax assets. Management periodically evaluates the recoverability of the deferred tax assets and the level of the valuation allowance. At such time as it is determined that it is more likely than not that the deferred tax assets are realizable, the valuation allowance will be reduced accordingly.

RELATED_PARTY_TRANSACTIONS

RELATED PARTY TRANSACTIONS	12 Months Ended
	Sep. 30, 2014
Related Party Transactions [Abstract]
Related Party Transactions Disclosure [Text Block]		8	RELATED PARTY TRANSACTIONS
	On November 28, 2012, pursuant to the Amended and Restated Consent, Note Amendment and Warrant Forfeiture Agreement dated October 24, 2012, between the Company and the holders of at least a majority in aggregate principal amount outstanding (“Majority Holders”) of each tranche of the Company’s convertible promissory notes issued (the October 2010 Notes, the January 2011 Notes, the October 2011 Notes and the February 2012 Note), all of such notes were amended to (a) extend the maturity date of October 1, 2013, (b) set the conversion price at $1.00, subject to adjustment as provided in the notes and (c) remove full-ratchet anti-dilution protection. In addition, the holders forfeited the warrants they received in connection with the issuance of the notes, and consented to the 2012 Bridge Financing, the issuance of the October 2012 Notes and to the subordination of their notes to these October 2012 Notes. The holders of the above mentioned notes included the following directors or entities beneficially owned by them: John Pappajohn, Walter Schindler, Andrew Sassine, Zachary McAdoo and former director George Kallins. The Company’s Chief Financial Officer, Paul Buck, was also a note holder.
	As a condition of the November 28, 2012 closing of the 2012 Bridge Financing, the Company also entered into Employment Compensation Forfeiture and Exchange Agreements (“Forfeiture and Exchange Agreements”) with three of its executive officers, George Carpenter, Paul Buck and Michael Darkoch. Pursuant to these agreements, the executives agreed to waive receipt of and release the Company from the payment of 50% of their salaries accrued from August 31, 2010 to September 30, 2012 (amount waived was $56,250 for George Carpenter, $66,083 for Paul Buck and $43,333 for Michael Darkoch), in consideration for which the Company agreed to issue to such executives a certain number of shares of its Common Stock (56,250 for George Carpenter, 66,083 for Paul Buck and 43,333 for Michael Darkoch). Any remaining accrued salary remains outstanding and shall be paid (i) from time to time at the discretion of the Board to the extent the Board determines that such payment will not jeopardize the ability of the Company to continue as a going concern; or (ii) upon the closing of any single financing transaction (including a single financing transaction that contemplates multiple closings) in which the Company receives proceeds of $5 million or more. Additionally, where applicable, the executives agreed to waive receipt of and release the Company from the payment of any previously approved bonus award. Under the agreements, the Company agreed to indemnify the executives for all federal and state income tax payable and actually paid by the executive related directly to the receipt of the Common Stock, the per share value of which was not expected to be more than the conversion price of the October 2012 Notes which was $0.04718 per share.
	On February 6, 2013, the Company filed with the SEC Schedule 14f-1 in connection with the change in a majority of the Board. The 14f-1 was mailed to stockholders of record by February 13, 2013. On December 10, 2012, the Board had approved the appointment of the “New Board Members” to the Board of the Company to fill vacancies. The New Board Members took office as directors on February 25, 2013. Messrs. Turner and Sassine were appointed to the Board as nominees of Equity Dynamics, Inc. (“Equity Dynamics”), an entity owned by Board member John Pappajohn, pursuant to the terms of the governance agreement, dated November 28, 2012, between the Company and Equity Dynamics. Messrs. Tierney and Follman were appointed to the Board as nominees of SAIL Capital Partners, which is affiliated with Board member Walter Schindler, pursuant to the terms of the governance agreement, dated November 28, 2012, between the Company and SAIL Capital Partners.
	On August 12, 2013, all of the holders of $1.00 convertible notes (“$1 Note(s)”) (see Note 4 above) converted $1 Note(s) in the aggregate principal amount of $6,363,900, plus $1,359,400 in accrued interest thereon, into shares of Common Stock at the price of $0.25 per share. The conversion followed an amendment of the Notes to permit a temporary reduction in the conversion price from $1.00 per share to $0.25 per share. All $1 Note holders consented to the amendment and converted their Notes and interest thereon at a conversion price of $0.25 per share of Common Stock with the resultant issuance of 30,893,419 shares. The $1 Note holders included four affiliates of the Company:
		⋅	Mr. Pappajohn, a Director of the Company, converted six notes with an aggregate principal amount of $1,511,700, plus $317,900 of interest thereon, into 7,318,229 shares of Common Stock;
		⋅	Mr. Sassine, a Director of the Company, converted two notes with an aggregate principal amount of $700,000, plus $174,600 of interest thereon, into 3,498,200 shares of Common Stock;
		⋅	Mr. McAdoo, a Director of the Company, converted three notes held by the Zanett Opportunity Fund, Ltd., of which he is the President, with an aggregate principal amount of $380,000, plus $57,200 of interest thereon, into 1,748,720 shares of Common Stock;
		⋅	Mr. Buck, the Chief Financial Officer of the Company, converted one note with a principal amount of $75,000, plus $14,900 of interest thereon, into 359,450 shares of Common Stock.
	On October 8, 2013, the Board granted to the Company’s two executive officers and two senior managers (collectively, the “Managers”) options to purchase shares of its Common Stock pursuant to the 2012 Option Plan at an exercise price of $0.25 per share as follows: George Carpenter 435,000 shares, Paul Buck 470,000 shares, Stewart Navarre 385,000 shares and Brian MacDonald 310,000. These options vest pro-rata over 12 months starting from the date of grant. Pursuant to the Employment Compensation Forfeiture and Exchange Agreement dated December 16, 2013, the Managers agreed to forego a portion of their salaries in fiscal year 2014 as follows: George Carpenter $98,000, Paul Buck $106,500, Stewart Navarre $83,600 and Brian MacDonald $66,700. These Managers were paid out of the salaries earned and accrued during fiscal years 2012 and 2013. The accruals to be paid out were equivalent to the fiscal year 2014 salaries that each of the Managers agreed to forego in lieu of receiving options.
	Transactions with Henry T. Harbin, Former Director
	Dr. Henry Harbin resigned his directorship on November 18, 2012, by which time the Company had accrued $90,000 to be paid on Dr. Harbin’s consulting agreement. Dr. Harbin’s consulting agreement started in January 2010, and continued until December 2012. Effective January 2013, Dr. Harbin entered into a new consulting agreement with the Company originally terminating on December 31, 2013 and with two automatic annual renewal options. These renewal options would engage Dr. Harbin for his consulting services through December 2015. As compensation for his new consulting services, on January 14, 2013 Dr. Harbin was granted options to purchase 850,000 shares of Common Stock at an exercise price of $0.04718 per share. These shares vest evenly over 36 months starting at the date of the grant. Because Dr. Harbin understood the Company’s cash constraints, he forgave the Company’s $90,000 debt to him, which had been accrued on his earlier consulting agreement.
	Transactions with John Pappajohn, Director
	As of September 2013, the Company had accrued $200,000 of consulting fees and expenses pursuant to a Board approved agreement with Equity Dynamics, a company owned by Mr. Pappajohn. Mr. Pappajohn assigned the $200,000 debt to multiple third parties and on September 20, 2013, the Company entered into subscription agreements with five accredited investors who had been assigned that debt and issued them in aggregate 800,000 shares of Common Stock at $0.25 per share.
	On November 28, 2012, an October 2012 Note in the aggregate principal amount of $500,000 was issued to Mr. Pappajohn in exchange for $300,000 cash and the two short-term loans aggregating $200,000 which had been issued on April 26, 2012 and May 25, 2012 in exchange for cash. On January 25, 2013, Mr. Pappajohn converted $200,000 of his October 2012 Note plus interest thereon into 4,300,551 shares of Common Stock at a conversion price of $0.04718 per share. On March 21, 2013, Mr. Pappajohn converted the remaining $300,000 of his October 2012 Note plus interest thereon into 6,538,258 shares of Common Stock at a conversion price of $0.04718 per share.
	On August 30, 2013, Mr. Pappajohn purchased an aggregate of 400,000 shares of Common Stock at a price of $0.25 per share pursuant to a private placement offering memorandum for which the Company received gross aggregate cash proceeds of $100,000.
	On September 22, 2014, Mr. Pappajohn purchased $200,000 of September 2014 Notes which are convertible into shares of Common Stock (i) automatically upon the closing of a qualified offering of no less than $5 million at a conversion price equal to the lesser of $0.25 or 70% of the lowest cost of Common Stock offered by the Company, but in no event less than $0.10 per share or (ii) voluntarily within 15 days of maturity at the lesser of a conversion price equal to $0.25 or the lowest cost of Common Stock offered by the Company, but in no event less than $0.10 per share.
	Transactions with Walter L. Schindler, Director
	Mr. Schindler is a Director and the Managing Partner of SAIL Capital Partners which is the general partner of all the SAIL entities except for SAIL Holding, LLC which is controlled directly by Mr. Schindler. On August17, 2012, the Company issued an October 2012 Note in the aggregate principal amount of $100,000 to SAIL Holdings, LLC in exchange for cash. On October 26, 2012 the Company issued three additional October 2012 Notes for the aggregate amount of $90,000 in exchange for cash to the following SAIL entities:- SAIL 2010 Co-Investment Partners, LP, $20,000; SAIL 2011 Co-Investment Partners, LP, $20,000; SAIL Venture Partners II, LP $50,000.
	On January 31, 2013, the SAIL entities converted all their convertible notes in the aggregate principal amount of $1,440,000 and $226,200 of interest thereon into 5,631,699 shares of Common Stock. Of these conversions $250,000 was an October 2010 Note together with interest of $53,300 converted into 303,313 shares of Common Stock at a conversion price of $1.00 per share. $1,000,000 in aggregate were six January 2011 Notes together with interest of $166,500 which converted into 1,166,503 shares of Common Stock at a conversion price of $1.00. And lastly, $190,000 in aggregate were four October 2012 Notes together with interest of $6,400 which converted into 4,161,883 shares of Common Stock at a conversion price of $0.04718 per share. All these shares were converted by Walter Schindler, on behalf of all the various SAIL entities.
	On September 12, 2013, SAIL Venture Management, LLC (“SAIL VM”) an entity managed by Mr. Schindler, entered into a subscription agreement to settle a debt with Common Stock at $0.25 per share. $45,500 was owed by the Company for expenses paid on its behalf by SAIL VM which was issued 181,974 shares of Common Stock to settle that debt.
	On July 11, 2014, SAIL Pre-Exit Acceleration fund, L.P, an entity managed by Mr. Schindler, entered into a subscription agreement to purchase 40,000 shares of Common Stock at $0.25 per share for which the Company received gross cash proceeds of $10,000.
	Transactions with Thomas T. Tierney, Chairman of the Board
	On August 21, and September 6, of 2012 two October 2012 Notes in the aggregate principal amount of $200,000 were issued in exchange for cash to the Thomas T. and Elizabeth C. Tierney Family Trust (the “Tierney Family Trust”), an accredited investor, of which Thomas T. Tierney is a trustee. As of February 25, 2013, Mr. Tierney was empanelled as a Director of the Company. As of January 31, 2013, the Tierney Family Trust converted its two October 2012 Notes, in aggregate $200,000, plus interest thereon into 4,403,349 shares of Common Stock at a conversion price of $0.04718 per share.
	The Tierney Family Trust has made multiple additional investments pursuant to a series of subscription agreements all of which were the result of private placements of unregistered stock at $0.25 per share. All individual transactions were in tranches of $100,000 for the purchase of 400,000 shares and the Company received gross cash proceeds of $100,000 on each occasion. These transactions occurred on the following dates: March 18, July 22, August 30 and September 9 of 2013 and January 13, February 12 and July 8, of 2014. In aggregate the Tierney Family Trust has purchased 2,800,000 shares at $0.25 per share for $700,000 gross cash proceeds to the Company.
	On September 22, 2014, the Tierney Family Trust purchased $200,000 of September 2014 Notes which are convertible into shares of Common Stock (i) automatically upon the closing of a qualified offering of no less than $5 million at a conversion price equal to the lesser of $0.25 or 70% of the lowest cost of Common Stock offered by the Company, but in no event less than $0.10 per share or (ii) voluntarily within 15 days of maturity at the lesser of a conversion price equal to $0.25 or the lowest cost of Common Stock offered by the Company, but in no event less than $0.10 per share.
	Transactions with Robert J. Follman, Director
	On October 19, 2012, an October 2012 Note in the aggregate principal amount of $200,000 was issued in exchange for cash to the Trust of Robert J. Follman and Carole A. Follman, dated August 14, 1979 (the “Follman Trust”), an accredited investor, of which Robert J. Follman is a trustee. As of February 25, 2013, Mr. Follman was empanelled as a Director of the Company. On June 14, 2013, the Follman Trust converted their October 2012 Note and interest thereon to into 4,491,310 shares of Common Stock at a conversion price $0.04718 per share.
	The Follman Trust has made multiple additional investments pursuant to a series of subscription agreements all of which were the result of private placements of unregistered stock at $0.25 per share. All individual transactions were in tranches of $100,000 for the purchase of 400,000 shares and the Company received gross cash proceeds of $100,000 on each occasion. These transactions occurred on the following dates: August 16 and September 11 of 2013 and January 17, February 14 and July 8 of 2014. In aggregate the Follman Trust has purchased 2,000,000 shares at $0.25 per share for $500,000 gross cash proceeds to the Company.
	Transactions with Andrew Sassine, Director
	On November 28, 2012, we issued an additional October 2012 Note in the principal amount of $25,000 to Mr. Sassine in exchange for cash. On February 25, 2013, Mr. Sassine was empanelled as a Director of the Company. On April 30, 2013, Mr. Sassine converted his October 2012 Note and interest thereon to into 550,021 shares of Common Stock at a conversion price $0.04718 per share.
	Transactions with George Carpenter, Chief Executive Officer
	On November 28, 2012, we issued October 2012 Notes in exchange for cash in the aggregate principal amount of $50,000 to Mr. George Carpenter, the Chief Executive Officer of the Company. On March 27, 2013, Mr. Carpenter converted his October 2012 Note and interest thereon into 1,091,299 shares of Common Stock at a conversion price of $0.04718 per share.
	On September 25, 2013, the Board approved a consulting agreement effective May 1, 2013, for marketing services provided by Decision Calculus Associates, an entity operated by Mr. Carpenter’s spouse, Jill Carpenter. For the period from May 1, 2013 through to September 30, 2014, we have paid $155,000 to Decision Calculus Associates and have an accounts payable balance of a further $15,000.
	On January 28, 2014, Mr. and Mrs. Carpenter invested $50,000 for 200,000 shares of Common Stock at $0.25 per share pursuant to a subscription agreement for which the Company received gross cash proceeds of $50,000.
	On July 11, 2014, Mr. and Mrs. Carpenter invested $12,500 for 50,000 shares of Common Stock at $0.25 per share pursuant to a subscription agreement for which the Company received gross cash proceeds of $12,500.
	Transactions with Paul Buck, Chief Financial Officer
	Mr. Buck has made multiple additional investments pursuant to a series of subscription agreements all of which were the result of private placements of unregistered stock at $0.25 per share. On February 22 and August 28 of 2013 Mr. Buck made two investments $12,500 each for an aggregate 100,000 shares of Common Stock at $0.25 per share pursuant to a subscription agreements for which the Company received gross cash proceeds of $25,000.
	On February 12, 2014, Mr. Buck invested $25,000 for 100,000 shares of Common Stock at $0.25 per share pursuant to a subscription agreement for which the Company received gross cash proceeds of $25,000.
	On July 8, 2014, Mr. Buck invested $12,500 for 50,000 shares of Common Stock at $0.25 per share pursuant to a subscription agreement for which the Company received gross cash proceeds of $12,500.
	Transactions with Extuple Limited Partnership, Greater than 5% Stockholder
	On October 25, 2012, an October 2012 Note in the aggregate principal amount of $200,000 was issued in exchange for cash to Extuple Limited Partnership (“Extuple”), an accredited investor, of which Philip Deck is the managing partner. On June 14, 2013, Extuple converted $50,000 of their October 2012 Note and interest thereon to into 1,121,237 shares of Common Stock at a conversion price $0.04718 per share. On September 30, 2013, Extuple converted the remaining $150,000 of their October 2012 Note and interest thereon into 3,449,555 shares of Common Stock at a conversion price $0.04718 per share.
	On April 1, 2013, Extuple invested $300,000 for 1,200,000 shares of Common Stock at a price of $0.25 per share pursuant to a subscription agreement. The Company received gross cash proceeds of $300,000.
	Transactions with Mark and Jill Oman, Greater than 5% Stockholder
	On November 29, 2012, an October 2012 Note in the aggregate principal amount of $250,000 was issued in exchange for cash to Mark and Jill Oman (the “Omans”), who are accredited investors. On April 30, 2013, the Omans converted their October 2012 Note and interest thereon into 5,500,212 shares of Common Stock at a conversion price of $0.04718 per share.
	On June 11, 2013, the Omans invested an additional $250,000 for an aggregate of 1,000,000 shares of Common Stock at a price of $0.25 per share pursuant to a subscription agreement. The Company received gross cash proceeds of $250,000. Of the issued shares, 800,000 shares are held and their own name and 200,000 are held in the name of an entity which they control.
	On August 30, 2013, the Omans invested a further $100,000 for an aggregate of 400,000 shares of Common Stock at a price of $0.25 per share pursuant to a subscription agreement for which the Company received gross cash proceeds of $100,000.
	On September 22, 2014, Oman Ventures LLC, of which Mr. Oman is the President, purchased $200,000 of September 2014 Notes which are convertible into shares of Common Stock (i) automatically upon the closing of a qualified offering of no less than $5 million at a conversion price equal to the lesser of $0.25 or 70% of the lowest cost of Common Stock offered by the Company, but in no event less than $0.10 per share or (ii) voluntarily within 15 days of maturity at the lesser of a conversion price equal to $0.25 or the lowest cost of Common Stock offered by the Company, but in no event less than $0.10 per share.

LOSS_PER_SHARE

LOSS PER SHARE	12 Months Ended
	Sep. 30, 2014
Earnings Per Share [Abstract]
Earnings Per Share [Text Block]		9	LOSS PER SHARE
	In accordance with ASC 260-10 (formerly SFAS 128, “Computation of Earnings Per Share”), basic net income (loss) per share is computed by dividing the net income (loss) to common stockholders for the period by the weighted average number of common shares outstanding during the period. Diluted net income (loss) per share is computed by dividing the net income (loss) for the period by the weighted average number of common and dilutive common equivalent shares outstanding during the period.  For the fiscal years ended September 30, 2014 and 2013, the Company has excluded all common equivalent shares from the calculation of diluted net loss per share as such securities are anti-dilutive.
	A summary of the net income (loss) and shares used to compute net income (loss) per share for the fiscal years ended September 30, 2014 and 2013 is as follows:
			2014		2013
	Net Loss for computation of basic and diluted net loss per share:
	From continuing operations		$	-2,660,100	$	-10,888,000
	From discontinued operations			-2,700		-19,400
	Net loss		$	-2,662,800	$	-10,907,400
	Basic and Diluted net loss per share:
	From continuing operations		$	-0.03	$	-0.14
	From discontinued operations			0		0
	Basic net loss per share		$	-0.03	$	-0.14
	Basic and Diluted weighted average shares outstanding			99,326,519		75,800,179
	Anti-dilutive common equivalent shares not included in the computation of dilutive net loss per share:
	Convertible debt			137,500		22,468,186
	Warrants			1,139,415		1,163,976
	Options			11,930,872		8,009,536

COMMITMENTS_AND_CONTINGENT_LIA

COMMITMENTS AND CONTINGENT LIABILITIES	12 Months Ended
	Sep. 30, 2014
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies Disclosure [Text Block]		10	COMMITMENTS AND CONTINGENT LIABILITIES
	Litigation
	From time to time, the Company may be involved in litigation relating to claims arising out of the Company’s operations in the ordinary course of business. Other than as set forth below, the Company is not currently party to any legal proceedings, the adverse outcome of which, in the Company’s management’s opinion, individually or in the aggregate, would have a material adverse effect on the Company’s results of operations or financial position.
	Since June 2009, the Company has been involved in litigation against Leonard J. Brandt, a stockholder, former Director and the Company’s former Chief Executive Officer (“Brandt”) in the Delaware Chancery Court, the Supreme Court of the State of Delaware and the United States District Court for the Central District of California. Other than current actions described below, the Company has prevailed in all actions or the matters have been dismissed.
	On April 11, 2011, Brandt and his family business partnership Brandt Ventures, GP, filed an action in the Superior Court for the State of California, Orange County against the Company, one of its stockholders, SAIL Venture Partner, LP, and Mr. David Jones, a former member of the Board, alleging breach of a promissory note agreement entered into by Brandt Ventures, GP and the Company and alleging that Mr. Brandt was wrongfully terminated as Chief Executive Officer in April, 2009.  The Company was served with a summons and complaint in the action on July 19, 2011.
	On November 1, 2011, Mr. Brandt and Brandt Ventures filed an amended complaint amending their claims and adding new claims against the same parties. On March 12, 2012, the court sustained demurrers to certain of the counts against each defendant. On March 22, 2012, the plaintiffs filed a second amended complaint modifying certain of their claims, but did not add new claims. On February 6, 2013, the plaintiffs moved for leave to amend the second amended complaint and file a third amended complaint. On March 6, 2013, the Court granted leave to amend, but awarded fees and costs for the defendants to again make dispositive motions. The third amended complaint adds a claim for breach of the promissory note and seeks to foreclose on the collateral securing the note obligation.  In addition, Mr. Brandt is seeking approximately $170,000 of severance and compensatory and punitive damages in connection with his termination.  In interrogatory responses served on January 26, 2013, Mr. Brandt for the first time identified that he seeks damages in connection with his termination exceeding $9,000,000.  Mr. Brandt has proffered no credible evidence to support damages in this amount, and the Company believes this claim for damages is without merit.  The plaintiffs also seek rescission of a $250,000 loan made by Brandt Ventures, GP to the Company which was converted into Common Stock in accordance with its terms and restitution of the loan amount.
	Discovery is ongoing and the Company continues to aggressively defend the action. A trial date had originally been set for May 2014; however, plaintiffs’ counsel requested a continuance until August 2014 to which the Company agreed. Subsequently on June 18, 2014, at plaintiffs’ counsel’s request, the Company entered into a Standstill and Tolling Agreement whereby the plaintiffs agreed to execute a dismissal of all the claims without prejudice with the ability to re-file the third amended complaint, without change, on or before June 18, 2015. The Company believes that this agreement effectively postpones further litigation of this matter by six to twelve months. The Company believes that the third amended complaint, like the prior complaints, is without merit. The Company has not accrued any amounts related to this matter. The action is captioned Leonard J. Brandt and Brandt Ventures, GP v. CNS Response, Inc., Sail Venture Partners and David Jones, case no. 30-2011-00465655-CU-WT-CJC.
	The Company has expended substantial resources to pursue the defense of legal proceedings initiated by Mr. Brandt.  The Company does not know whether Mr. Brandt will institute additional claims against the Company and the defense of any such claims could involve the expenditure of additional resources by the Company.
	Lease Commitments
	The Company has its current Headquarters and Neurometric Services business premises located at 85 Enterprise, Aliso Viejo, California 92656 since February 2010.  On February 6, 2014, we signed a 24 month extension to our lease for our current location. The lease period commenced on February 1, 2014 and terminates on January 31, 2016. The rent for months one through 13 is $4,349 per month; the months of February 2014 and January 2015 are abated; the rent for months 14 through 24 is $4,523 per month.
	The Company leased space for its Clinical Services, our discontinued operation, under an operating lease.  The original lease terminated on February 28, 2010 and a 37 month extension to the lease was negotiated commencing April 1, 2010 and terminating April 30, 2013. The 3,542 square foot facility had an average cost for the lease term of $5,100 per month. These premises were vacated on September 30, 2012 and the Company fully accrued the remaining outstanding balance of the lease through April 30, 2013, which had remained outstanding. As a key term in the lease extension, the landlord had required that the Company, rather than NTC, bear the financial responsibility for this lease. We negotiated a settlement with the landlord to structure the payoff of the lease with a promissory note of $50,000 bearing interest at 5% per annum with 13 payments over 12 months. This note has been paid off as of September 30, 2014.
	The Company incurred rent expense from continuing operations of $45,000 and $47,700 for the fiscal years ended September 30, 2014 and 2013, respectively.
	On November 8, 2010, we entered into a financial lease to acquire EEG equipment costing $15,900.  The term of the lease was 48 months ending October 2014 and the monthly payment is $412. As of September 30, 2014 we had fully paid off lease obligation.
	On April 24, 2013, we entered into a second financial lease to acquire additional EEG equipment costing $8,900.  The term of the lease is 36 months ending May 2016 with a monthly payment of $325. As of September 30, 2014 the remaining lease obligation is $6,000 of which $3,500 and $2,500 are due in fiscal years 2015 and 2016, respectively.
			Payments due by period
					Less						More
	Contractual Obligations		Total		than 1 year		1 to 3 years		3 to 5 years		than 5 years
	Operating Lease Obligations		$	67,300	$	49,200	$	18,100		-		-
	Capital Lease Obligations			6,000		3,500		2,500		-		-
	Total		$	73,300	$	52,700	$	20,600		-		-

SIGNIFICANT_CUSTOMERS

SIGNIFICANT CUSTOMERS	12 Months Ended
	Sep. 30, 2014
Risks and Uncertainties [Abstract]
Concentration Risk Disclosure [Text Block]		11	SIGNIFICANT CUSTOMERS
	For the fiscal year ended September 30, 2014, four customers accounted for 68% of Neurometric Services revenue and three customers accounted for 53% of accounts receivable at September 30, 2014.
	For the fiscal year ended September 30, 2013, four customers accounted for 51% of Neurometric Services revenue and three customers accounted for 50% of accounts receivable at September 30, 2013.

SUMMARY_OF_SIGNIFICANT_ACCOUNT1

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	12 Months Ended
	Sep. 30, 2014
Accounting Policies [Abstract]
Basis Of Accounting Policy [Policy Text Block]	Basis of Presentation
	The accompanying consolidated financial statements of the Company have been prepared pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (the “SEC”) and are in accordance with accounting principles generally accepted in the United States of America.
Consolidation, Policy [Policy Text Block]	Basis of Consolidation
	The audited consolidated financial statements include the accounts of the Company, an inactive parent company, and its wholly owned subsidiaries CNS California and NTC, which is accounted for as a discontinued operation (Refer to Note 3.Discontinued Operations Transaction). All significant intercompany transactions have been eliminated on consolidation.
Use of Estimates, Policy [Policy Text Block]	Use of Estimates
	The preparation of the consolidated financial statements requires management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenue and expense, and related disclosure of contingent assets and liabilities. On an ongoing basis, the Company evaluates its estimates, including those related to revenue recognition, doubtful accounts, intangible assets, income taxes, valuation of equity instruments, accrued liabilities, contingencies and litigation. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ materially from these estimates.
Cash and Cash Equivalents, Policy [Policy Text Block]	Cash
	The Company deposits its cash with major financial institutions and may at times exceed the federally insured limit of $250,000.  At September 30, 2014 cash exceeds the federally insured limit by $990,600.  The Company believes that the risk of loss is minimal. To date, the Company has not experienced any losses related to cash deposits with financial institutions.
Derivatives, Policy [Policy Text Block]	Derivative Liabilities
	The Company evaluates all of its agreements to determine if such instruments have derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the consolidated statements of operations. For stock-based derivative financial instruments, the Company uses a weighted average Black-Scholes option pricing model to value the derivative instruments at inception and on subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date. As of September 30, 2014, the Company’s only derivative financial instrument were a series of convertible notes with a “reset” and “dilutive issuance” clause within the notes relating to the conversion price from dilutive share issuance. See Notes 4 & 5.
Fair Value of Financial Instruments, Policy [Policy Text Block]	Fair Value of Financial Instruments
	ASC 825-10 (formerly Statement of Financial Accounting Standards (“SFAS”) 107, “Disclosures about Fair Value of Financial Instruments”) defines financial instruments and requires disclosure of the fair value of financial instruments held by the Company. The Company considers the carrying amount of cash, accounts receivable, other receivables, accounts payable and accrued liabilities, to approximate their fair values because of the short period of time between the origination of such instruments and their expected realization.
	The Company also analyzes all financial instruments with features of both liabilities and equity under ASC 480-10 (formerly SFAS 150, “Accounting for Certain Financial Instruments with Characteristics of Both Liabilities and Equity”), ASC 815-10 (formerly SFAS 133, “Accounting for Derivative Instruments and Hedging Activities”) and ASC 815-40 (formerly EITF 00-19, “Accounting for Derivative Financial Instruments Indexed to, and Potentially Settled in, a Company’s Own Stock”).
	The Company adopted ASC 820-10 (formerly SFAS 157, “Fair Value Measurements”) on January 1, 2008. ASC 820-10 defines fair value, establishes a three-level valuation hierarchy for disclosures of fair value measurement and enhances disclosure requirements for fair value measures. The three levels are defined as follows:
		⋅	Level 1 inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets;
		⋅	Level 2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the assets or liability, either directly or indirectly, for substantially the full term of the financial instruments; and
		⋅	Level 3 inputs to the valuation methodology are unobservable and significant to the fair value.
	The Company used Level 2 inputs for its valuation methodology for the conversion option liability in determining the fair value using the Black-Scholes option-pricing model with the following assumption inputs:
			September 30, 2014
	Annual dividend yield		-
	Expected life (years)		0.5
	Risk-free interest rate		0.03	%
	Expected volatility		55	%
			Carrying Value		Fair Value Measurements at
			As of		September 30, 2014
			September 30,		Using Fair Value Hierarchy
			2014		Level 1		Level 2		Level 3
	Liabilities
	Secured Convertible Debt		$	1,475,800		-	$	1,650,000		-
	Conversion option liability			153,100				153,100
	Total		$	1,628,900	$	-	$	1,803,100	$	-
	For the years ended September 30, 2014 and 2013, the Company had $153,100 and $0 derivative liabilities respectively. For the fiscal year ending September 30, 2014 and 2013, the Company had a change in fair valuation thereon of $26,100 and $0 respectively.  As at September 30, 2014, the Company did not identify any other assets or liabilities that are required to be presented on the balance sheet at fair value in accordance with ASC 825-10
Trade and Other Accounts Receivable, Unbilled Receivables, Policy [Policy Text Block]	Accounts Receivable
	The Company estimates the collectability of customer receivables on an ongoing basis by reviewing past-due invoices and assessing the current creditworthiness of each customer.  Allowances are provided for specific receivables deemed to be at risk for collection which as of September 30, 2014 and 2013 are $1,200 and $5,900 respectively.
Property, Plant and Equipment, Policy [Policy Text Block]	Furniture and Equipment
	Furniture and Equipment, which are recorded at cost, consist of office furniture and equipment and are depreciated over their estimated useful life on a straight-line basis.  The useful life of these assets is estimated to be between three and five years.  Depreciation for the years ended September 30, 2014 and 2013 was $10,300 and $13,000 respectively.  Accumulated depreciation at September 30, 2014 and 2013 was $75,000 and $64,800, respectively.
Offerings Costs Policy [Policy Text Block]	Offering Costs
	The Company applies ASC 505-10, “Costs of an Equity Transaction,” for recognition of offering costs. In accordance with ASC 505-10, the Company treats incremental direct costs incurred to issue shares classified as equity, as a reduction of the proceeds. Direct costs incurred before shares classified as equity are issued are classified as an asset until the stock is issued. Indirect costs such as management salaries or other general and administrative expenses and deferred costs of an aborted offering are expensed.
Impairment Or Disposal Of Long-Lived Assets, Including Intangible Assets, Policy [Policy Text Block]	Long-Lived Assets
	As required by ASC 350-30 (formerly SFAS No. 144, Accounting for the Impairment or Disposal of Long-Lived Assets), the Company reviews the carrying value of its long-lived assets whenever events or changes in circumstances indicate that the historical cost-carrying value of an asset may no longer be appropriate. The Company assesses recoverability of the carrying value of the asset by estimating the future net cash flows expected to result from the asset, including eventual disposition. If the future net cash flows are less than the carrying value of the asset, an impairment loss is recorded equal to the difference between the asset’s carrying value and fair value. No impairment loss was recorded for the years ended September 30, 2014 and 2013.
	The Company adopted Accounting standards update (“ASU”) 2012-02, Intangibles—Goodwill and Other (Topic 350): Testing Indefinite-Lived Intangible Assets for Impairment. The new guidance is intended to reduce the complexity and costs of the annual impairment test for indefinite-lived intangible assets by allowing companies to make a qualitative evaluation about the likelihood of impairment to determine whether it should perform a quantitative impairment test.
Trade And Other Accounts Payable [Policy Text Block]	Accounts Payable
	Accounts payable consists of trade payables of which $501,600 are for legal services. As of September 2014 we had accounts payable write-backs of $44,000 for long held-debts which have been in dispute and there has been no collection activity for over four years.
	Between November 11, 2013, and December 20, 2013, the Company issued an aggregate of 1,446,380 shares of its Common Stock, as full and complete settlement of trade debt totaling an aggregate of $1,466,800 owed to two creditors who are also accredited investors. The fair market value of the shares that were issued in these transactions was determined to be $0.25 per share. The excess value of $1,105,200 over the fair market value of the issued shares was booked to Other Income (Expense) as a gain on extinguishment of debt.
Revenue Recognition, Deferred Revenue [Policy Text Block]	Deferred Revenue
	Deferred revenue represents revenue collected but not earned as of September 30, 2014. This represents a philanthropic grant for the payment of PEER Reports ordered for the Walter Reed clinical trial during calendar 2014, which are otherwise not paid for by Walter Reed or Fort Belvoir. These deferred revenue grant funds as of September 30, 2014, are $45,900. As of September 30, 2013 there was no deferred revenue balance.
Revenue Recognition, Policy [Policy Text Block]	Revenues
	The Company recognizes revenue on services, being the delivery of PEER Reports to medical providers, in accordance with the Financial Accounting Standards Board (“FASB”) ASC No. 605, “Revenue Recognition.”  In all cases, revenue is recognized when we have persuasive evidence of an arrangement, a determinable fee, when collection is considered to be reasonable assured and the services are delivered.
Research and Development Expense, Policy [Policy Text Block]	Research and Development Expenses
	The Company charges all research and development expenses to operations as incurred.
Advertising Costs, Policy [Policy Text Block]	Advertising Expenses
	The Company charges all advertising expenses to operations as incurred. For the years ended September 30, 2014 and 2013 advertising expenses were $3,100 and $14,400 respectively.
Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]	Stock-Based Compensation
	The Company has adopted ASC 718-20 (formerly SFAS No. 123R, Share-Based Payment - revised 2004) and related interpretations which establish the accounting for equity instruments exchanged for employee services. Under ASC 718-20, share-based compensation cost to option grantee, being employees, directors and consultants, and is measured at the grant date based on the calculated fair value of the award (see Note 5 for further discussion on valuations). The expense is recognized over the option grantees’ requisite service period, generally the vesting period of the award.
Inducement To Convert Debt [Policy Text Block]	Inducement to Convert Debt
	According to ASC 470-20-55, when a convertible debt instrument is converted to equity pursuant to an inducement offer, the debtor recognizes an expense equal to the fair value of all securities and other consideration transferred in the transaction in excess of the fair value of securities issuable pursuant to the original conversion terms. The fair value of the securities or other consideration is measured as of the date the inducement offer is accepted by the convertible debt holder.
	As an inducement to convert debt, the Company offered to all holders of $1 per share convertible notes (“$1 Notes”) an opportunity to convert that debt, and associated accrued interest, at $0.25 per share for a limited 60 day period with the proviso that 100% of the holders of the $1 Notes agreed to the conversion terms. All holders’ of $1 Notes agreed to convert and the transaction closed on August 12, 2013.
	Fair value of debt conversion on August 12, 2013
	Based on the volume of shares traded on the open market, during the period April 1, 2013 through to August 12, 2013, the date of the conversion of all $1 Notes, management judged that the Company’s stock was not actively traded as only $277,636 worth of stock was traded on 42 of 95 trading days during this period at prices ranging from $0.41 to $2.50. There was a contemporaneous transaction whereby shares corresponding to $827,500 of a $2.0 million private placement of common stock purchased at a price of $0.25 per share by accredited third party investors. Given the low volume of stock that was traded, compared to the volume of the private placement of common stock, management’s judgment was that the pricing of the private placement of common stock at $0.25 per share represented a better determinant of fair value of the Company’s common stock upon the conversion of debt on August 12, 2013.
	As the original conversion terms of the notes were at $1 into one share of common stock with a fair value of $0.25, consequently, the three additional shares offered on conversion at $0.25 each represent the inducement to convert.
Income Tax, Policy [Policy Text Block]	Income Taxes
	The Company accounts for income taxes under the asset and liability method.  Deferred tax assets and liabilities are recognized for future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases.  Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which the temporary differences are expected to be recovered or settled.  The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.  Valuation allowances are recorded, when necessary, to reduce deferred tax assets to the amount expected to be realized.
	As a result of the implementation of certain provisions of ASC 740,  Income  Taxes, (formerly FIN 48,  Accounting for Uncertainty in Income Taxes – An Interpretation of FASB Statement No. 109),  (“ASC 740”), which clarifies the accounting and disclosure for uncertainty in tax positions, as defined. ASC 740 seeks to reduce the diversity in practice associated with certain aspects of the recognition and measurement related to accounting for income taxes.  The Company adopted the provisions of ASC 740 and have analyzed filing positions in each of the federal and state jurisdictions where required to file income tax returns, as well as all open tax years in these jurisdictions.  We have identified the U.S. federal and California as our "major" tax jurisdictions.  Generally, we remain subject to Internal Revenue Service examination of our 2008 through 2012 U.S. federal income tax returns, and remain subject to California Franchise Tax Board examination of our 2008 through 2012 California Franchise Tax Returns.  However, we have certain tax attribute carryforwards which will remain subject to review and adjustment by the relevant tax authorities until the statute of limitations closes with respect to the year in which such attributes are utilized.
	We believe that our income tax filing positions and deductions will be sustained on audit and do not anticipate any adjustments that will result in a material change to our financial position.  Therefore, no reserves for uncertain income tax positions have been recorded pursuant to ASC 740.  In addition, we did not record a cumulative effect adjustment related to the adoption of ASC 740.  Our policy for recording interest and penalties associated with income-based tax audits is to record such items as a component of income taxes.
Comprehensive Income, Policy [Policy Text Block]	Comprehensive Income (Loss)
	ASC 220-10 (formerly, SFAS No. 130, Reporting Comprehensive Income), requires disclosure of all components of comprehensive income (loss) on an annual and interim basis.  Comprehensive income (loss) is defined as the change in equity of a business enterprise during a period from transactions and other events and circumstances from non-owner sources.  The Company’s comprehensive income (loss) is the same as its reported net income (loss) for the years ended September 30, 2014 and 2013.
Earnings Per Share, Policy [Policy Text Block]	Earnings (Loss) per Share
	The Company has adopted GAAP regarding earnings (loss) per share, which requires presentation of basic and diluted earnings (loss) per share in conjunction with the disclosure of the methodology used in computing such earnings (loss) per share.
	Basic earnings (loss) per share are computed by dividing income (loss) available to common stockholders by the weighted average common shares outstanding during the period. Diluted earnings (loss) per share takes into account the potential dilution that could occur if securities or other contracts to issue Common Stock were exercised and converted into Common Stock.
New Accounting Pronouncements, Policy [Policy Text Block]	Recent Accounting Pronouncements
	Apart from the below-mentioned recent accounting pronouncements, there are no new accounting pronouncements that are currently applicable to the Company.
	In August, 2014, the FASB has issued Accounting Standards Update (ASU) No. 2014-15, Presentation of Financial Statements—Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern. ASU 2014-15 is intended to define management’s responsibility to evaluate whether there is substantial doubt about an organization’s ability to continue as a going concern and to provide related footnote disclosures. The Company does not expect the adoption of the standard update to have a material impact on its consolidated financial position or results of operations.
	In August 2014, the FASB issued Accounting Standards Update (ASU) No. 2014-13, Consolidation (Topic 810): Measuring the Financial Assets and the Financial Liabilities of a Consolidated Collateralized Financing Entity. The amendments in this ASU will apply to a reporting entity that is required to consolidate a collateralized financing entity under the Variable Interest Entities guidance when: (1) the reporting entity measures all of the financial assets and the financial liabilities of that consolidated collateralized financing entity at fair value in the consolidated financial statements based on other Codification Topics; and (2) the changes in the fair values of those financial assets and financial liabilities are reflected in earnings. The Company does not expect the adoption of the standard update to have a material impact on its consolidated financial position or results of operations.
	In June 2014, the FASB issued ASU No. 2014-12, Compensation – Stock Compensation (Topic 718): Accounting for Share-Based Payments When the Terms of an Award Provide That a Performance Target Could Be Achieved after the Requisite Service Period. The amendments in the ASU require that a performance target that affects vesting and that could be achieved after the requisite service period be treated as a performance condition. A reporting entity should apply existing guidance in Topic 718, Compensation – Stock Compensation, as it relates to awards with performance conditions that affect vesting to account for such awards. The performance target should not be reflected in estimating the grant-date fair value of the award. Compensation cost should be recognized in the period in which it becomes probable that the performance target will be achieved and should represent the compensation cost attributable to the period(s) for which the requisite service has already been rendered. The Company does not expect the adoption of the standard update to have a material impact on its consolidated financial position or results of operations.
	In April 2014, the FASB issued ASU No. 2014-08, Presentation of Financial Statements (Topic 205) and Property, Plant, and Equipment (Topic 360) — Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity. The amendments in ASU 2014-08 change the criteria for reporting discontinued operations while enhancing disclosures in this area. Under the new guidance, only disposals representing a strategic shift in operations should be presented as discontinued operations. Those strategic shifts should have a major effect on the organization’s operations and financial results. In addition, the new guidance requires expanded disclosures about discontinued operations. The Company does not expect the adoption of the standard update to have a material impact on its consolidated financial position or results of operations.

SUMMARY_OF_SIGNIFICANT_ACCOUNT2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	12 Months Ended
	Sep. 30, 2014
Accounting Policies [Abstract]
Fair Value Inputs, Liabilities, Quantitative Information [Table Text Block]	The Company used Level 2 inputs for its valuation methodology for the conversion option liability in determining the fair value using the Black-Scholes option-pricing model with the following assumption inputs:
		September 30, 2014
	Annual dividend yield	-
	Expected life (years)	0.5
	Risk-free interest rate	0.03	%
	Expected volatility	55	%
Fair Value Measurements, Recurring and Nonrecurring [Table Text Block]		Carrying Value		Fair Value Measurements at
		As of		September 30, 2014
		September 30,		Using Fair Value Hierarchy
		2014		Level 1		Level 2		Level 3
	Liabilities
	Secured Convertible Debt	$	1,475,800		-	$	1,650,000		-
	Conversion option liability		153,100				153,100
	Total	$	1,628,900	$	-	$	1,803,100	$	-

DISCONTINUED_OPERATIONS_Tables

DISCONTINUED OPERATIONS (Tables)	12 Months Ended
	Sep. 30, 2014
Discontinued Operations and Disposal Groups [Abstract]
Schedule of Disposal Groups, Including Discontinued Operations, Income Statement, Balance Sheet and Additional Disclosures [Table Text Block]	Revenues, income before income taxes and net loss of NTC which are included in discontinued operations are as follows:
		2014		2013
	Neuro-Therapy Clinic
	Revenues	$	-	$	-
	Expenses		2,700		19,400
	Operating Loss before taxes	$	-2,700	$	-19,400
	Taxes		-		-
	Net Loss	$	-2,700	$	-19,400
	The assets and liabilities of NTC are as follows:
		2014		2013
	ASSETS:
	Assets of Discontinued Operations	$	-	$	-
	LIABILITIES:
	Accounts Payable	$	86,600	$	88,500
	Accrued Payroll Liabilities		90,600		130,000
	Note Payable (see Note 10)		-		50,000
	Liabilities of Discontinued Operations	$	177,200	$	268,500

CONVERTIBLE_DEBT_AND_EQUITY_FI1

CONVERTIBLE DEBT AND EQUITY FINANCINGS (Tables)	12 Months Ended
	Sep. 30, 2014
Debt Disclosure [Abstract]
Convertible Debt [Table Text Block]			As of September 30, 2014
							Carrying
			Balance		Discount		Value
	Note Type and Investor	Due Date	($)		($)		($)
	Senior Secured 5% Notes Convertible at $0.25
	(the “September 2014 Notes”)
	RSJ Private Equity	3/21/16	$	750,000	$	-67,900	$	682,100
	4 Accredited Investors	3/21/16		300,000		-28,900		271,100
	John Pappajohn	3/21/16		200,000		-25,800		174,200
	Tierney Family Trust	3/21/16		200,000		-25,800		174,200
	Oman Ventures	3/21/16		200,000		-25,800		174,200
	Total Secured Convertible Promissory (September 2014) Notes		$	1,650,000	$	-174,200	$	1,475,800

DERIVATIVE_LIABILITIES_Tables

DERIVATIVE LIABILITIES (Tables)	12 Months Ended
	Sep. 30, 2014
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Table Text Block]	The Black-Scholes option-pricing model with the following assumption inputs:
		November 27, 2012				November 28, 2012
	Annual dividend yield		-				-
	Expected life (years)		3.5				3.5
	Risk-free interest rate		0.36	%			0.35	%
	Expected volatility		113.52	%			113.62	%
	The Black-Scholes option-pricing model with the following assumption inputs:
		September 22 to 29, 2014		September 30, 2014
	Annual dividend yield			-
	Expected life (years)	0.5		0.5
	Risk-free interest rate	0.03% - 0.05	%	0.03	%
	Expected volatility	55	%	55	%

STOCKHOLDERS_DEFICIT_Tables

STOCKHOLDERS' DEFICIT (Tables)	12 Months Ended
	Sep. 30, 2014
Stockholders' Equity Note [Abstract]
Schedule of Debt Conversions [Table Text Block]	Below is a summary of all promissory notes conversions:
			Shares of
			Common			Conversion		Conversion			Principal
	Conversion of Notes		Stock			Date		Price			Amount			Interest			Total
	Fiscal Year 2012
	October 2012 Notes:
	Unsecured convertible notes			40,000		9/19/12		$	0.04718		$	1,800		$	100		$	1,900
	Fiscal Year 2013
	October 2010 Notes: Senior			303,313		1/31/13		$	1		$	250,000		$	53,300		$	303,300
	subordinated convertible notes			13,943,539		8/12/13		$	0.25			2,773,900			712,000			3,485,900
	Total October 2010 Notes:			14,246,852							$	3,023,900		$	765,300		$	3,789,200
	January 2011 Notes:			1,166,503		1/31/13		$	1		$	1,000,000		$	166,500		$	1,166,500
	Subordinated convertible notes			7,336,500		8/12/13		$	0.25			1,500,000			334,100			1,834,100
	Total January 2011 Notes:			8,503,003							$	2,500,000		$	500,600		$	3,000,600
	October 2011 Notes:
	Subordinated convertible notes			9,205,680		8/12/13		$	0.25		$	2,000,000		$	301,400		$	2,301,400
	February 2012 Notes:
	Unsecured convertible note			407,700		8/12/13		$	0.25		$	90,000		$	11,900		$	101,900
	October 2012 Notes:
	Unsecured convertible notes			44,085,044		01/18/13 through 09/30/13		$	0.04718		$	1,998,200		$	81,800		$	2,080,000
	Total of Notes Converted in Fiscal 2013			76,448,279							$	9,612,100		$	1,661,000		$	11,273,100
	Total of Notes Converted			76,488,279							$	9,613,900		$	1,661,100		$	11,275,000
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]	The following assumptions were made in estimating the fair value:
			2014				2013
	Annual dividend yield			-				-
	Expected life (years)			5				5
	Risk-free interest rate			1.42% - 1.76	%			0.62% - 0.79	%
	Expected volatility			116% - 129	%			380% - 393	%
	Fair value of options granted		$	0.21			$	0.05 - 0.25
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block]	Stock-based compensation expense is recognized over the employees’ or service provider’s requisite service period, generally the vesting period of the award. Stock-based compensation expense included in the accompanying statements of operations for the year ended September 30, 2014 and 2013 is as follows:
			For the fiscal year ended
			September 30,
			2014				2013
	Cost of Neurometric Services revenues		$	5,100			$	10,600
	Research			65,500				92,700
	Product Development			249,700				113,300
	Sales and marketing			87,700				155,500
	General and administrative			600,700				885,200
	Total		$	1,008,700			$	1,257,300
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]	A summary of stock option activity is as follows:
		Number of				Weighted Average
			Shares			Exercise Price
	Outstanding at September 30, 2012			546,746		$	17.08
	Granted			9,205,000			0.05
	Exercised			-			-
	Forfeited			-2,152			14.1
	Outstanding at September 30, 2013			9,749,594		$	1
	Granted			2,725,000			0.25
	Exercised			-			-
	Forfeited			-57,095			12.67
	Outstanding at September 30, 2014			12,417,499		$	0.84
Schedule of Share-based Compensation, Activity [Table Text Block]	Following is a summary of the status of options outstanding at September 30, 2014:
							Weighted			Weighted			Vested and			Weighted			Aggregate Intrinsic
							Average			Average			Exercisable at			Average			Value at $0.22 price
	Exercise			Number			Contractual			Exercise			September			Remaining			per share at
	Price			of Shares			Life			Price			30, 2014			Life (Years)			September 30, 2014
	$	0.04718			8,920,300			10 years		$	0.04718			6,538,494			8.2		$	1,541,606
	$	0.25			2,527,605			10 years			0.25			1,951,216			9			-
	$	0.26			425,000			10 years			0.26			35,417			9.8			-
	$	3			42,670			10 years			3			37,929			7.5			-
	$	3.6			28,648			10 years			3.6			28,648			1.9			-
	$	3.96			32,928			10 years			3.96			32,928			1.9			-
	$	9			4,525			10 years			9			4,525			2.1			-
	$	12			28,535			10 years			12			28,535			5.7			-
	$	14.1			10,000			10 years			14.1			8,958			6.5			-
	$	15.3			1,373			10 years			15.3			1,373			4			-
	$	16.5			262,441			10 years			16.5			262,441			5.4			-
	$	17.7			953			10 years			17.7			953			1.9			-
	$	24			4,667			10 years			24			4,667			3.2			-
	$	26.7			32,297			10 years			26.7			32,297			3			-
	$	28.8			11,767			10 years			28.8			11,767			3.5			-
	$	32.7			83,790			10 years			32.7			83,790			2.8			-
		Total			12,417,499					$	0.843			9,063,938			4.79		$	1,541,606
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]	The warrant activity for the period starting October 1, 2012, through September 30, 2014, is described as follows:
			Exercise
	Warrants		Price				Issued, Surrendered or Expired in Connection With:
	2,164,440		$				Warrants outstanding at October 1, 2012
	-1,617,345			3			Warrants forfeited pursuant to the Amended and Restated Consent, Note Amendment and Warrant Forfeiture Agreement dated October 24, 2012
	127,173			0.04718			These warrants were issued to Monarch Capital who acted as placement agents in raising $60,000 from one investor who purchased October 2012 Notes pursuant to the 2012 Bridge Note October Purchase Agreement.
	519,288			0.04718			These warrants due to be issued to Tony Pullen who acted as placement agents in raising $350,000 from three investors who purchased October 2012 Notes pursuant to the 2012 Bridge Note October Purchase Agreement.
	152,000			0.275			These warrants were issued to Monarch Capital who acted as placement agents in raising $380,000 from twelve accredited investors who purchased common stock, par value $0.001 per share, in private placement agreements dated February 20, 2013 and May 23, 2013.
	100,000			0.25			These warrants were issued to D&D Securities Inc. in connection with the Company’s private offering to select accredited investors of shares of restricted common stock at a private of $0.25 per share, in a private placement agreement dated February 20, 2013.
	52,000			0.275			These warrants were issued to Monarch Capital who acted as placement agents in raising $520,000 from five accredited investors who purchased common stock, par value $0.001 per share, in a private placement agreement dated May 23, 2013.
	1,497,556		$	3.03			Warrants outstanding at September 30, 2013
	120,000			0.275			Warrants issued to Monarch Capital who acted as placement agents in raising $300,000 from 11 accredited investors who purchased restricted common stock, par value $0.001 per share, in a private placement agreements dated October 2, 2013 and January 8, 2014.
	32,200			0.25			Warrants issued to D&D Securities Inc. who acted as placement agents in raising $115,000 from three accredited investors who purchased restricted common stock, par value $0.001 per share, in a private placement agreement dated January 8, 2014.
	-519,288			0.04718			Warrants exercised as of January 29, 2013.
	-89,021			0.04718			Warrants exercised as of June 20, 2014.
	-226,703			$9.00 to $9.90			Warrants expired
	814,744		$	3.07			Warrants outstanding at September 30, 2014

INCOME_TAXES_Tables

INCOME TAXES (Tables)	12 Months Ended
	Sep. 30, 2014
Income Tax Disclosure [Abstract]
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]	Reconciliations of the provision (benefit) for income taxes to the amount compiled by applying the statutory federal income tax rate to profit (loss) before income taxes is as follows for each of the fiscal years ended September 30:
		2014				2013
	Federal income tax (benefit) at statutory rates			-34	%			-34	%
	Stock-based compensation			-0.2	%			3	%
	Nondeductible interest expense			-				4	%
	Extinguishment of debt			1.5	%			-2	%
	Change in valuation allowance			-5	%			3	%
	True-ups and other adjustments			-26.9	%			-
	State tax benefit			-3.4	%			9	%
	Inducement to convert			-				17	%
Schedule of Deferred Tax Assets and Liabilities [Table Text Block]	Temporary differences between the financial statement carrying amounts and bases of assets and liabilities that give rise to significant portions of deferred taxes relate to the following at September 30, 2014 and 2013:
			2014			2013
	Deferred income tax assets:
	Net operating loss carryforward		$	13,083,200		$	15,370,600
	Deferred interest, consulting and compensation liabilities			1,529,800			1,168,300
	Amortization			-			2,900
	Deferred income tax assets – other			5,800			4,300
				14,618,800			16,546,100
	Deferred income tax liabilities—other			-1,600			-
	Deferred income tax asset—net before valuation allowance			14,617,200			16,546,100
	Valuation allowance			-14,617,200			-16,546,100
	Deferred income tax asset—net		$	-		$	-

LOSS_PER_SHARE_Tables

LOSS PER SHARE (Tables)	12 Months Ended
	Sep. 30, 2014
Earnings Per Share [Abstract]
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	A summary of the net income (loss) and shares used to compute net income (loss) per share for the fiscal years ended September 30, 2014 and 2013 is as follows:
		2014		2013
	Net Loss for computation of basic and diluted net loss per share:
	From continuing operations	$	-2,660,100	$	-10,888,000
	From discontinued operations		-2,700		-19,400
	Net loss	$	-2,662,800	$	-10,907,400
	Basic and Diluted net loss per share:
	From continuing operations	$	-0.03	$	-0.14
	From discontinued operations		0		0
	Basic net loss per share	$	-0.03	$	-0.14
	Basic and Diluted weighted average shares outstanding		99,326,519		75,800,179
	Anti-dilutive common equivalent shares not included in the computation of dilutive net loss per share:
	Convertible debt		137,500		22,468,186
	Warrants		1,139,415		1,163,976
	Options		11,930,872		8,009,536

COMMITMENTS_AND_CONTINGENT_LIA1

COMMITMENTS AND CONTINGENT LIABILITIES (Tables)	12 Months Ended
	Sep. 30, 2014
Commitments and Contingencies Disclosure [Abstract]
Contractual Obligation, Fiscal Year Maturity Schedule [Table Text Block]		Payments due by period
				Less						More
	Contractual Obligations	Total		than 1 year		1 to 3 years		3 to 5 years		than 5 years
	Operating Lease Obligations	$	67,300	$	49,200	$	18,100		-		-
	Capital Lease Obligations		6,000		3,500		2,500		-		-
	Total	$	73,300	$	52,700	$	20,600		-		-

NATURE_OF_OPERATIONS_Details_T

NATURE OF OPERATIONS (Details Textual) (USD $)	12 Months Ended	3 Months Ended
	Sep. 30, 2014	Mar. 26, 2013
Nature Of Operations [Line Items]
Entity Incorporation, State Country Name	Delaware
Entity Incorporation, Date of Incorporation	20-Mar-87
Private Placement [Member]
Nature Of Operations [Line Items]
Proceeds from Issuance of Private Placement		$2,500,000
Private Placement [Member] | Twenty Accredited Investors [Member]
Nature Of Operations [Line Items]
Stock issued for purchase of common stock (in shares)	6,940,000
Proceeds from Issuance of Private Placement	1,691,000
Gross Proceeds from Issuance of Private Placement	1,735,000
Payments of Stock Issuance Costs	44,000
Proceeds from Convertible Debt	1,650,000
Gross Proceeds from Issuance of Common Stock and Convertible Debt	3,385,000
Share Price	0.25

SUMMARY_OF_SIGNIFICANT_ACCOUNT3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) (Derivative Financial Instruments, Liabilities [Member])	0 Months Ended	1 Months Ended		12 Months Ended
	Sep. 29, 2014	Nov. 27, 2012	Nov. 28, 2012	Sep. 30, 2014
Derivative Financial Instruments, Liabilities [Member]
Fair Value Inputs, Liabilities, Quantitative Information [Line Items]
Annual dividend yield		0.00%	0.00%	0.00%
Expected life (years)	6 months	3 years 6 months	3 years 6 months	6 months
Risk-free interest rate		0.36%	0.35%	0.03%
Expected volatility	55.00%	113.52%	113.62%	55.00%

SUMMARY_OF_SIGNIFICANT_ACCOUNT4

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 1) (USD $)	Sep. 30, 2014
Liabilities
Secured Convertible Debt	$1,475,800
Conversion option liability	153,100
Total	1,628,900
Fair Value, Inputs, Level 1 [Member]
Liabilities
Secured Convertible Debt	0
Total	0
Fair Value, Inputs, Level 2 [Member]
Liabilities
Secured Convertible Debt	1,650,000
Conversion option liability	153,100
Total	1,803,100
Fair Value, Inputs, Level 3 [Member]
Liabilities
Secured Convertible Debt	0
Total	$0

SUMMARY_OF_SIGNIFICANT_ACCOUNT5

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Textual) (USD $)	4 Months Ended	12 Months Ended		2 Months Ended	3 Months Ended
	Aug. 12, 2013	Sep. 30, 2014	Sep. 30, 2013	Dec. 31, 2013	Mar. 26, 2013
Significant Accounting Policies [Line Items]
Property, Plant and Equipment, Depreciation Methods		straight-line basis
Depreciation		$10,300	$13,000
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment		75,000	64,800
Debt Instrument, Convertible, Conversion Price (in dollars per share)	$1
Accounts Payable, Trade		501,600
Stock Issued During Period, Value, Issued For Services			7,900
Advertising Expense		3,100	14,400
Cash, FDIC Insured Amount		250,000
Cash, Uninsured Amount		990,600
Derivative Liability, Current		153,100	0
Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net		26,100	0
Stock Traded, Value	277,636
Debt Instrument, Convertible, Terms of Conversion Feature		As the original conversion terms of the notes were at $1 into one share of common stock with a fair value of $0.25, consequently, the three additional shares offered on conversion at $0.25 each represent the inducement to convert.
Allowance for Doubtful Accounts Receivable		1,200	5,900
Accounts Payable, Write-backs		44,000
Deferred Revenue		45,900	0
Debt Instrument Conversion Vote Percentage	100.00%	100.00%
Two Creditors [Member]
Significant Accounting Policies [Line Items]
Stock Issued During Period, Shares, Issued For Services (in shares)				1,446,380
Stock Issued During Period, Value, Issued For Services				1,466,800
Extinguishment of Debt, Gain (Loss), Net of Tax				1,105,200
Share Price				$0.25
Accredited Third Party Investor [Member]
Significant Accounting Policies [Line Items]
Stock Issued During Period, Share Price	$0.25
Proceeds From Issuance Of Private Placement	827,500		2,000,000
Private Placement [Member]
Significant Accounting Policies [Line Items]
Proceeds From Issuance Of Private Placement					2,500,000
Private Placement [Member] | Accredited Third Party Investor [Member]
Significant Accounting Policies [Line Items]
Proceeds From Issuance Of Private Placement					$695,000
Minimum [Member]
Significant Accounting Policies [Line Items]
Property, Plant and Equipment, Useful Life		3 years
Stock Traded, Price	$0.41
Maximum [Member]
Significant Accounting Policies [Line Items]
Property, Plant and Equipment, Useful Life		5 years
Stock Traded, Price	$2.50

DISCONTINUED_OPERATIONS_Detail

DISCONTINUED OPERATIONS (Details) (USD $)	12 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Net Loss	($2,700)	($19,400)
Neuro-Therapy Clinic [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Revenues	0	0
Expenses	2,700	19,400
Operating Loss before taxes	-2,700	-19,400
Taxes	0	0
Net Loss	-2,700	-19,400
ASSETS:
Assets of Discontinued Operations	0	0
LIABILITIES:
Accounts Payable	86,600	88,500
Accrued Payroll Liabilities	90,600	130,000
Note Payable (see Note 10)	0	50,000
Liabilities of Discontinued Operations	$177,200	$268,500

CONVERTIBLE_DEBT_AND_EQUITY_FI2

CONVERTIBLE DEBT AND EQUITY FINANCINGS (Details) (USD $)	12 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Debt Instrument [Line Items]
Senior Secured 5% Notes Convertible at $0.25, Discount	($174,200)	$0
Senior Secured 5% Notes Convertible at $0.25, Carrying Value	1,475,800	0
September 2014 Notes [Member]
Debt Instrument [Line Items]
Senior Secured 5% Notes Convertible at $0.25, Balance	1,650,000
Senior Secured 5% Notes Convertible at $0.25, Discount	-174,200
Senior Secured 5% Notes Convertible at $0.25, Carrying Value	1,475,800
RSJ Private Equity [Member] | September 2014 Notes [Member]
Debt Instrument [Line Items]
Senior Secured 5% Notes Convertible at $0.25, Due Date	21-Mar-16
Senior Secured 5% Notes Convertible at $0.25, Balance	750,000
Senior Secured 5% Notes Convertible at $0.25, Discount	-67,900
Senior Secured 5% Notes Convertible at $0.25, Carrying Value	682,100
Accredited Investors [Member] | September 2014 Notes [Member]
Debt Instrument [Line Items]
Senior Secured 5% Notes Convertible at $0.25, Due Date	21-Mar-16
Senior Secured 5% Notes Convertible at $0.25, Balance	300,000
Senior Secured 5% Notes Convertible at $0.25, Discount	-28,900
Senior Secured 5% Notes Convertible at $0.25, Carrying Value	271,100
John Pappajohn [Member] | September 2014 Notes [Member]
Debt Instrument [Line Items]
Senior Secured 5% Notes Convertible at $0.25, Due Date	21-Mar-16
Senior Secured 5% Notes Convertible at $0.25, Balance	200,000
Senior Secured 5% Notes Convertible at $0.25, Discount	-25,800
Senior Secured 5% Notes Convertible at $0.25, Carrying Value	174,200
Tierney Family Trust [Member] | September 2014 Notes [Member]
Debt Instrument [Line Items]
Senior Secured 5% Notes Convertible at $0.25, Due Date	21-Mar-16
Senior Secured 5% Notes Convertible at $0.25, Balance	200,000
Senior Secured 5% Notes Convertible at $0.25, Discount	-25,800
Senior Secured 5% Notes Convertible at $0.25, Carrying Value	174,200
Oman Ventures [Member] | September 2014 Notes [Member]
Debt Instrument [Line Items]
Senior Secured 5% Notes Convertible at $0.25, Due Date	21-Mar-16
Senior Secured 5% Notes Convertible at $0.25, Balance	200,000
Senior Secured 5% Notes Convertible at $0.25, Discount	-25,800
Senior Secured 5% Notes Convertible at $0.25, Carrying Value	$174,200

CONVERTIBLE_DEBT_AND_EQUITY_FI3

CONVERTIBLE DEBT AND EQUITY FINANCINGS (Details Textual) (USD $)	12 Months Ended		24 Months Ended	12 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2013	Sep. 30, 2011	Sep. 30, 2012	Aug. 12, 2013	Sep. 26, 2010	Nov. 23, 2010	Feb. 29, 2012	Nov. 30, 2012
Debt Instrument [Line Items]
Debt Conversion, Original Debt, Amount	$0	$11,273,100	$11,275,000
Debt Conversion Original Debt Principal Amount		9,612,100	9,613,900
Debt Conversion Original Debt Interest Amount		1,661,000	1,661,100
Debt Conversion, Converted Instrument, Shares Issued		76,448,279	76,488,279
Amortization Of Discount On Bridge Notes Issued	5,000	662,300
Debt Instrument, Unamortized Discount	174,200	0	0
Debt Instrument, Convertible, Conversion Price						$1
Debt Instrument Conversion Vote Percentage	100.00%					100.00%
Induced Conversion of Convertible Debt Expense	0	5,792,500
Convertible Debt	1,475,800
Debt Instrument, Convertible, Terms of Conversion Feature	As the original conversion terms of the notes were at $1 into one share of common stock with a fair value of $0.25, consequently, the three additional shares offered on conversion at $0.25 each represent the inducement to convert.
Private Placement [Member]
Debt Instrument [Line Items]
Debt Instrument, Unamortized Discount					824,400
Convertible Debt					8,012,000
$1 Notes [Member]
Debt Instrument [Line Items]
Debt Conversion, Original Debt, Amount		7,723,300
Debt Conversion Original Debt Interest Amount		1,359,400
Debt Conversion, Converted Instrument, Shares Issued		30,893,419
Debt Instrument, Convertible, Conversion Price		$1	$1
Induced Conversion of Convertible Debt Expense		5,792,500
October 2010 Notes [Member]
Debt Instrument [Line Items]
Secured Debt, Current							3,000,000
Debt Instrument, Interest Rate, Stated Percentage							9.00%
Debt Conversion, Original Debt, Amount		3,789,200
Debt Conversion Original Debt Principal Amount		3,023,900
Debt Conversion Original Debt Interest Amount		765,259
Debt Conversion, Converted Instrument, Shares Issued		14,246,852
Warrants To Purchase Common Stock				503,998
Convertible Notes Payable				3,023,900
Debt Instrument, Convertible, Conversion Price		$1	$1
October 2010 Notes [Member] | Subordinated Convertible Notes [Member]
Debt Instrument [Line Items]
Debt Conversion, Original Debt, Amount		3,485,900
Debt Conversion Original Debt Principal Amount		2,773,900
Debt Conversion Original Debt Interest Amount		712,000
Debt Conversion, Converted Instrument, Shares Issued		13,943,539
Debt Instrument, Convertible, Conversion Price		$0.25	$0.25
January 2011 Notes [Member]
Debt Instrument [Line Items]
Secured Debt, Current								5,000,000
Debt Instrument, Interest Rate, Stated Percentage								9.00%
Debt Conversion, Original Debt, Amount		3,000,600
Debt Conversion Original Debt Principal Amount		2,500,000
Debt Conversion Original Debt Interest Amount		500,600
Debt Conversion, Converted Instrument, Shares Issued		8,503,003
Warrants To Purchase Common Stock				416,674
Convertible Notes Payable				2,500,000
January 2011 Notes [Member] | Subordinated Convertible Notes [Member]
Debt Instrument [Line Items]
Debt Conversion, Original Debt, Amount		1,834,100
Debt Conversion Original Debt Principal Amount		1,500,000
Debt Conversion Original Debt Interest Amount		334,100
Debt Conversion, Converted Instrument, Shares Issued		7,336,500
Debt Instrument, Convertible, Conversion Price		$0.25	$0.25
October 2011 Notes [Member]
Debt Instrument [Line Items]
Secured Debt, Current				2,000,000
Debt Instrument, Interest Rate, Stated Percentage				9.00%
Warrants To Purchase Common Stock					666,673
Convertible Notes Payable					2,000,000
Amortization Of Discount On Bridge Notes Issued		277,100
October 2011 Notes [Member] | Subordinated Convertible Notes [Member]
Debt Instrument [Line Items]
Debt Conversion Original Debt Principal Amount					2,000,000
Debt Conversion Original Debt Interest Amount					301,400
Debt Conversion, Converted Instrument, Shares Issued					9,205,680
February 2012 Notes [Member]
Debt Instrument [Line Items]
Unsecured Debt, Current									90,000
Debt Instrument, Interest Rate, Stated Percentage									9.00%
Amortization Of Discount On Bridge Notes Issued		15,000
Debt Instrument, Convertible, Conversion Price		$1	$1			$0.25
February 2012 Notes [Member] | Unsecured Convertible Notes [Member]
Debt Instrument [Line Items]
Debt Conversion Original Debt Principal Amount					90,000
Debt Conversion Original Debt Interest Amount					11,900
Debt Conversion, Converted Instrument, Shares Issued					407,700
Warrants To Purchase Common Stock					30,000
October 2012 Note [Member]
Debt Instrument [Line Items]
Debt Conversion, Converted Instrument, Shares Issued					40,000
Convertible Notes Payable					398,100					2,000,000
Amortization Of Discount On Bridge Notes Issued	0	370,200
Debt Instrument, Convertible, Conversion Price										$0.05
Short-term Debt, Total					400,000
Bridge Loan					2,000,000
October 2012 Note [Member] | Unsecured Convertible Notes [Member]
Debt Instrument [Line Items]
Debt Conversion, Original Debt, Amount					1,900
Debt Conversion Original Debt Principal Amount		1,998,200
Debt Conversion Original Debt Interest Amount		81,800
Debt Conversion, Converted Instrument, Shares Issued		44,085,044
Debt Instrument, Convertible, Conversion Price		$0.47	$0.47
Senior Notes [Member] | October 2010 Notes [Member]
Debt Instrument [Line Items]
Debt Conversion, Original Debt, Amount		303,300
Debt Conversion Original Debt Principal Amount		250,000
Debt Conversion Original Debt Interest Amount		53,300
Debt Conversion, Converted Instrument, Shares Issued		303,313
Debt Instrument, Convertible, Conversion Price		$1	$1
Senior Notes [Member] | January 2011 Notes [Member]
Debt Instrument [Line Items]
Debt Conversion, Original Debt, Amount		1,166,500
Debt Conversion Original Debt Principal Amount		1,000,000
Debt Conversion Original Debt Interest Amount		166,500
Debt Conversion, Converted Instrument, Shares Issued		1,166,503
Debt Instrument, Convertible, Conversion Price		$1	$1
September 2014 Notes [Member]
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	5.00%
Debt Instrument, Unamortized Discount	174,200
Debt Instrument, Convertible, Conversion Price	$0.25
Debt Instrument, Face Amount	$2,500,000
Debt Instrument, Term	18 months
Debt Instrument, Convertible, Terms of Conversion Feature	(i) automatically upon the closing of a qualified offering of no less than $5 million at a conversion price equal to the lesser of $0.25 or 70% of the lowest cost of Common Stock offered by the Company, but in no event less than $0.10 per share or (ii) voluntarily within 15 days of maturity at the lesser of a conversion price equal to $0.25 or the lowest cost of Common Stock offered by the Company, but in no event less than $0.10 per share.

DERIVATIVE_LIABILITIES_Details

DERIVATIVE LIABILITIES (Details) (Derivative Financial Instruments, Liabilities [Member])	0 Months Ended	1 Months Ended		12 Months Ended
	Sep. 29, 2014	Nov. 27, 2012	Nov. 28, 2012	Sep. 30, 2014
Derivatives, Fair Value [Line Items]
Annual dividend yield		0.00%	0.00%	0.00%
Expected life (years)	6 months	3 years 6 months	3 years 6 months	6 months
Risk-free interest rate		0.36%	0.35%	0.03%
Expected volatility	55.00%	113.52%	113.62%	55.00%
Minimum [Member]
Derivatives, Fair Value [Line Items]
Risk-free interest rate	0.03%
Maximum [Member]
Derivatives, Fair Value [Line Items]
Risk-free interest rate	0.05%

DERIVATIVE_LIABILITIES_Details1

DERIVATIVE LIABILITIES (Details Textual) (USD $)	1 Months Ended	12 Months Ended
	Nov. 28, 2012	Sep. 30, 2014	Sep. 30, 2013	Aug. 12, 2013	Nov. 30, 2012	Sep. 23, 2014
Derivatives, Fair Value [Line Items]
Debt Instrument, Convertible, Conversion Price				$1
Gains (Losses) on Extinguishment of Debt, Total	$556,300	$1,105,200	$556,300
Derivative Liability		153,100
October 2012 Note [Member]
Derivatives, Fair Value [Line Items]
Debt Instrument, Convertible, Conversion Price					$0.05
Derivative Financial Instruments, Liabilities [Member] | October 2012 Note [Member]
Derivatives, Fair Value [Line Items]
Debt Instrument, Convertible, Conversion Price	$1
Debt Instrument, Interest Rate, Stated Percentage	9.00%
Derivative Financial Instruments, Liabilities [Member] | September 2014 Notes [Member]
Derivatives, Fair Value [Line Items]
Proceeds from Convertible Debt		1,650,000
Derivative Liability		153,100				179,200
Derivative, Gain on Derivative		$26,100
Derivative Financial Instruments, Liabilities [Member] | Maximum [Member] | September 2014 Notes [Member]
Derivatives, Fair Value [Line Items]
Debt Instrument, Convertible, Conversion Price		$0.25
Derivative Financial Instruments, Liabilities [Member] | Minimum [Member] | September 2014 Notes [Member]
Derivatives, Fair Value [Line Items]
Debt Instrument, Convertible, Conversion Price		$0.10

STOCKHOLDERS_DEFICIT_Details

STOCKHOLDERS' DEFICIT (Details) (USD $)	12 Months Ended		24 Months Ended	12 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2013	Sep. 30, 2012	Aug. 12, 2013
Debt Conversion [Line Items]
Debt Conversion, Converted Instrument, Shares Issued		76,448,279	76,488,279
Debt Instrument, Convertible, Conversion Price					$1
Debt Conversion Original Debt Principal Amount		$9,612,100	$9,613,900
Debt Conversion Original Debt Interest Amount		1,661,000	1,661,100
Debt Conversion, Original Debt, Amount	0	11,273,100	11,275,000
October 2010 Notes [Member]
Debt Conversion [Line Items]
Debt Conversion, Converted Instrument, Shares Issued		14,246,852
Debt Instrument, Convertible, Conversion Price		$1	$1
Debt Conversion Original Debt Principal Amount		3,023,900
Debt Conversion Original Debt Interest Amount		765,259
Debt Conversion, Original Debt, Amount		3,789,200
October 2010 Notes [Member] | Subordinated Convertible Notes [Member]
Debt Conversion [Line Items]
Debt Conversion, Converted Instrument, Shares Issued		13,943,539
Debt Instrument, Convertible, Latest Date		12-Aug-13
Debt Instrument, Convertible, Conversion Price		$0.25	$0.25
Debt Conversion Original Debt Principal Amount		2,773,900
Debt Conversion Original Debt Interest Amount		712,000
Debt Conversion, Original Debt, Amount		3,485,900
January 2011 Notes [Member]
Debt Conversion [Line Items]
Debt Conversion, Converted Instrument, Shares Issued		8,503,003
Debt Conversion Original Debt Principal Amount		2,500,000
Debt Conversion Original Debt Interest Amount		500,600
Debt Conversion, Original Debt, Amount		3,000,600
January 2011 Notes [Member] | Subordinated Convertible Notes [Member]
Debt Conversion [Line Items]
Debt Conversion, Converted Instrument, Shares Issued		7,336,500
Debt Instrument, Convertible, Latest Date		12-Aug-13
Debt Instrument, Convertible, Conversion Price		$0.25	$0.25
Debt Conversion Original Debt Principal Amount		1,500,000
Debt Conversion Original Debt Interest Amount		334,100
Debt Conversion, Original Debt, Amount		1,834,100
October 2012 Note [Member] | Unsecured Convertible Notes [Member]
Debt Conversion [Line Items]
Debt Conversion, Converted Instrument, Shares Issued		44,085,044		40,000
Debt Instrument, Convertible, Earliest Date		18-Jan-13
Debt Instrument, Convertible, Latest Date		30-Sep-13		19-Sep-12
Debt Instrument, Convertible, Conversion Price		$0.05	$0.05	$0.05
Debt Conversion Original Debt Principal Amount		1,998,200		1,800
Debt Conversion Original Debt Interest Amount		81,800		100
Debt Conversion, Original Debt, Amount		2,080,000		1,900
October 2011 Notes [Member] | Subordinated Convertible Notes [Member]
Debt Conversion [Line Items]
Debt Conversion, Converted Instrument, Shares Issued		9,205,680
Debt Instrument, Convertible, Latest Date		12-Aug-13
Debt Instrument, Convertible, Conversion Price		$0.25	$0.25
Debt Conversion Original Debt Principal Amount		2,000,000
Debt Conversion Original Debt Interest Amount		301,400
Debt Conversion, Original Debt, Amount		2,301,400
February 2012 Notes [Member] | Unsecured Convertible Notes [Member]
Debt Conversion [Line Items]
Debt Conversion, Converted Instrument, Shares Issued		407,700
Debt Instrument, Convertible, Latest Date		12-Aug-13
Debt Instrument, Convertible, Conversion Price		$0.25	$0.25
Debt Conversion Original Debt Principal Amount		90,000
Debt Conversion Original Debt Interest Amount		11,900
Debt Conversion, Original Debt, Amount		101,900
Senior Notes [Member] | October 2010 Notes [Member]
Debt Conversion [Line Items]
Debt Conversion, Converted Instrument, Shares Issued		303,313
Debt Instrument, Convertible, Latest Date		31-Jan-13
Debt Instrument, Convertible, Conversion Price		$1	$1
Debt Conversion Original Debt Principal Amount		250,000
Debt Conversion Original Debt Interest Amount		53,300
Debt Conversion, Original Debt, Amount		303,300
Senior Notes [Member] | January 2011 Notes [Member]
Debt Conversion [Line Items]
Debt Conversion, Converted Instrument, Shares Issued		1,166,503
Debt Instrument, Convertible, Latest Date		31-Jan-13
Debt Instrument, Convertible, Conversion Price		$1	$1
Debt Conversion Original Debt Principal Amount		1,000,000
Debt Conversion Original Debt Interest Amount		166,500
Debt Conversion, Original Debt, Amount		$1,166,500

STOCKHOLDERS_DEFICIT_Details_1

STOCKHOLDERS' DEFICIT (Details 1) (USD $)	12 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Annual dividend yield	0.00%	0.00%
Expected life (years)	5 years	5 years
Risk-free interest rate, Minimum	1.42%	0.62%
Risk-free interest rate, Maximum	1.76%	0.79%
Expected volatility, Minimum	116.00%	380.00%
Expected volatility, Maximum	129.00%	393.00%
Fair value of options granted (in dollars per share)	$0.21
Maximum [Member]
Fair value of options granted (in dollars per share)		0.25
Minimum [Member]
Fair value of options granted (in dollars per share)		0.05

STOCKHOLDERS_DEFICIT_Details_2

STOCKHOLDERS' DEFICIT (Details 2) (USD $)	12 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Stock-based compensation expenses	$1,008,700	$1,257,300
Cost of Neurometric Services revenues [Member]
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Stock-based compensation expenses	5,100	10,600
Research [Member]
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Stock-based compensation expenses	65,500	92,700
Product Development [Member]
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Stock-based compensation expenses	249,700	113,300
Sales and marketing [Member]
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Stock-based compensation expenses	87,700	155,500
General and administrative [Member]
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Stock-based compensation expenses	$600,700	$885,200

STOCKHOLDERS_DEFICIT_Details_3

STOCKHOLDERS' DEFICIT (Details 3) (Employee Stock Option [Member], USD $)	12 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Employee Stock Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of Shares, Outstanding at the beginning of the period	9,749,594	546,746
Number of Shares, Granted	2,725,000	9,205,000
Number of Shares, Exercised	0	0
Number of Shares, Forfeited	-57,095	-2,152
Number of Shares, Outstanding at the end of the period	12,417,499	9,749,594
Weighted Average Exercise Price, Outstanding at the beginning of the period	$1	$17.08
Weighted Average Exercise Price, Granted	$0.25	$0.05
Weighted Average Exercise Price, Exercised	$0	$0
Weighted Average Exercise Price, Forfeited	$12.67	$14.10
Weighted Average Exercise Price, Outstanding at the end of the period	$0.84	$1

STOCKHOLDERS_DEFICIT_Details_4

STOCKHOLDERS' DEFICIT (Details 4) (Employee Stock Option [Member], USD $)	12 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2012
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Options Outstanding, Exercise Price	$0.84	$1	$17.08
Options Outstanding, Number of Shares	12,417,499
Options Outstanding, Weighted Average Exercise Price	$0.84
Options Outstanding, Vested and Exercisable	9,063,938
Options Outstanding, Weighted Average Remaining Life (Years)	4 years 9 months 14 days
Options Outstanding, Aggregate Intrinsic Value	$1,541,606
Stock Option One [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Options Outstanding, Exercise Price	$0.05
Options Outstanding, Number of Shares	8,920,300
Options Outstanding, Weighted Average Contractual Life	10 years
Options Outstanding, Weighted Average Exercise Price	$0.05
Options Outstanding, Vested and Exercisable	6,538,494
Options Outstanding, Weighted Average Remaining Life (Years)	8 years 2 months 12 days
Options Outstanding, Aggregate Intrinsic Value	1,541,606
Stock Option Two [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Options Outstanding, Exercise Price	$0.25
Options Outstanding, Number of Shares	2,527,605
Options Outstanding, Weighted Average Contractual Life	10 years
Options Outstanding, Weighted Average Exercise Price	$0.25
Options Outstanding, Vested and Exercisable	1,951,216
Options Outstanding, Weighted Average Remaining Life (Years)	9 years
Options Outstanding, Aggregate Intrinsic Value	0
Stock Option Three [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Options Outstanding, Exercise Price	$0.26
Options Outstanding, Number of Shares	425,000
Options Outstanding, Weighted Average Contractual Life	10 years
Options Outstanding, Weighted Average Exercise Price	$0.26
Options Outstanding, Vested and Exercisable	35,417
Options Outstanding, Weighted Average Remaining Life (Years)	9 years 9 months 18 days
Options Outstanding, Aggregate Intrinsic Value	0
Stock Option Four [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Options Outstanding, Exercise Price	$3
Options Outstanding, Number of Shares	42,670
Options Outstanding, Weighted Average Contractual Life	10 years
Options Outstanding, Weighted Average Exercise Price	$3
Options Outstanding, Vested and Exercisable	37,929
Options Outstanding, Weighted Average Remaining Life (Years)	7 years 6 months
Options Outstanding, Aggregate Intrinsic Value	0
Stock Option Five [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Options Outstanding, Exercise Price	$3.60
Options Outstanding, Number of Shares	28,648
Options Outstanding, Weighted Average Contractual Life	10 years
Options Outstanding, Weighted Average Exercise Price	$3.60
Options Outstanding, Vested and Exercisable	28,648
Options Outstanding, Weighted Average Remaining Life (Years)	1 year 10 months 24 days
Options Outstanding, Aggregate Intrinsic Value	0
Stock Option Six [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Options Outstanding, Exercise Price	$3.96
Options Outstanding, Number of Shares	32,928
Options Outstanding, Weighted Average Contractual Life	10 years
Options Outstanding, Weighted Average Exercise Price	$3.96
Options Outstanding, Vested and Exercisable	32,928
Options Outstanding, Weighted Average Remaining Life (Years)	1 year 10 months 24 days
Options Outstanding, Aggregate Intrinsic Value	0
Stock Option Seven [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Options Outstanding, Exercise Price	$9
Options Outstanding, Number of Shares	4,525
Options Outstanding, Weighted Average Contractual Life	10 years
Options Outstanding, Weighted Average Exercise Price	$9
Options Outstanding, Vested and Exercisable	4,525
Options Outstanding, Weighted Average Remaining Life (Years)	2 years 1 month 6 days
Options Outstanding, Aggregate Intrinsic Value	0
Stock Option Eight [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Options Outstanding, Exercise Price	$12
Options Outstanding, Number of Shares	28,535
Options Outstanding, Weighted Average Contractual Life	10 years
Options Outstanding, Weighted Average Exercise Price	$12
Options Outstanding, Vested and Exercisable	28,535
Options Outstanding, Weighted Average Remaining Life (Years)	5 years 8 months 12 days
Options Outstanding, Aggregate Intrinsic Value	0
Stock Option Nine [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Options Outstanding, Exercise Price	$14.10
Options Outstanding, Number of Shares	10,000
Options Outstanding, Weighted Average Contractual Life	10 years
Options Outstanding, Weighted Average Exercise Price	$14.10
Options Outstanding, Vested and Exercisable	8,958
Options Outstanding, Weighted Average Remaining Life (Years)	6 years 6 months
Options Outstanding, Aggregate Intrinsic Value	0
Stock Option Ten [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Options Outstanding, Exercise Price	$15.30
Options Outstanding, Number of Shares	1,373
Options Outstanding, Weighted Average Contractual Life	10 years
Options Outstanding, Weighted Average Exercise Price	$15.30
Options Outstanding, Vested and Exercisable	1,373
Options Outstanding, Weighted Average Remaining Life (Years)	4 years
Options Outstanding, Aggregate Intrinsic Value	0
Stock Option Eleven [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Options Outstanding, Exercise Price	$16.50
Options Outstanding, Number of Shares	262,441
Options Outstanding, Weighted Average Contractual Life	10 years
Options Outstanding, Weighted Average Exercise Price	$16.50
Options Outstanding, Vested and Exercisable	262,441
Options Outstanding, Weighted Average Remaining Life (Years)	5 years 4 months 24 days
Options Outstanding, Aggregate Intrinsic Value	0
Stock Option Twelve [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Options Outstanding, Exercise Price	$17.70
Options Outstanding, Number of Shares	953
Options Outstanding, Weighted Average Contractual Life	10 years
Options Outstanding, Weighted Average Exercise Price	$17.70
Options Outstanding, Vested and Exercisable	953
Options Outstanding, Weighted Average Remaining Life (Years)	1 year 10 months 24 days
Options Outstanding, Aggregate Intrinsic Value	0
Stock Option Thirteen [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Options Outstanding, Exercise Price	$24
Options Outstanding, Number of Shares	4,667
Options Outstanding, Weighted Average Contractual Life	10 years
Options Outstanding, Weighted Average Exercise Price	$24
Options Outstanding, Vested and Exercisable	4,667
Options Outstanding, Weighted Average Remaining Life (Years)	3 years 2 months 12 days
Options Outstanding, Aggregate Intrinsic Value	0
Stock Option Fourteen [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Options Outstanding, Exercise Price	$26.70
Options Outstanding, Number of Shares	32,297
Options Outstanding, Weighted Average Contractual Life	10 years
Options Outstanding, Weighted Average Exercise Price	$26.70
Options Outstanding, Vested and Exercisable	32,297
Options Outstanding, Weighted Average Remaining Life (Years)	3 years
Options Outstanding, Aggregate Intrinsic Value	0
Stock Option Fifteen [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Options Outstanding, Exercise Price	$28.80
Options Outstanding, Number of Shares	11,767
Options Outstanding, Weighted Average Contractual Life	10 years
Options Outstanding, Weighted Average Exercise Price	$28.80
Options Outstanding, Vested and Exercisable	11,767
Options Outstanding, Weighted Average Remaining Life (Years)	3 years 6 months
Options Outstanding, Aggregate Intrinsic Value	0
Stock Option Sixteen [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Options Outstanding, Exercise Price	$32.70
Options Outstanding, Number of Shares	83,790
Options Outstanding, Weighted Average Contractual Life	10 years
Options Outstanding, Weighted Average Exercise Price	$32.70
Options Outstanding, Vested and Exercisable	83,790
Options Outstanding, Weighted Average Remaining Life (Years)	2 years 9 months 18 days
Options Outstanding, Aggregate Intrinsic Value	$0

STOCKHOLDERS_DEFICIT_Details_5

STOCKHOLDERS' DEFICIT (Details 5) (USD $)	12 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Minimum [Member]
Class of Warrant or Right [Line Items]
Weighted Average Exercise Price, Outstanding at the end of the period	$0.05
Maximum [Member]
Class of Warrant or Right [Line Items]
Weighted Average Exercise Price, Outstanding at the end of the period	$9.90
Warrant One [Member]
Class of Warrant or Right [Line Items]
Warrants Issued	120,000	127,173
Warrants Exercised	-519,288
Warrants Issued, Exercise Price	$0.28	$0.05
Warrants Exercised, Exercise Price	$0.05
Warrant Two [Member]
Class of Warrant or Right [Line Items]
Warrants Issued	32,200	519,288
Warrants Exercised	-89,021
Warrants Issued, Exercise Price	$0.25	$0.05
Warrants Exercised, Exercise Price	$0.05
Warrant Three [Member]
Class of Warrant or Right [Line Items]
Warrants Issued		152,000
Warrants Issued, Exercise Price		$0.28
Warrant Four [Member]
Class of Warrant or Right [Line Items]
Warrants Issued		100,000
Warrants Issued, Exercise Price		$0.25
Warrant Five [Member]
Class of Warrant or Right [Line Items]
Warrants Issued		52,000
Warrants Issued, Exercise Price		$0.28
Warrant [Member]
Class of Warrant or Right [Line Items]
Warrants Outstanding, Balance at End of the period	1,497,556	2,164,440
Warrants Forfeited		-1,617,345
Warrants Expired	-226,703
Warrants Outstanding, Balance at End of the period	814,744	1,497,556
Weighted Average Exercise Price, Outstanding at the beginning of the period	$3.03
Warrants Forfeited, Exercise Price		$3
Weighted Average Exercise Price, Outstanding at the end of the period	$3.07	$3.03
Warrant [Member] | Minimum [Member]
Class of Warrant or Right [Line Items]
Warrants Expired, Exercise Price	$9
Warrant [Member] | Maximum [Member]
Class of Warrant or Right [Line Items]
Warrants Expired, Exercise Price	$9.90

STOCKHOLDERS_DEFICIT_Details_T

STOCKHOLDERS' DEFICIT (Details Textual) (USD $)	1 Months Ended	3 Months Ended				12 Months Ended		24 Months Ended	1 Months Ended	12 Months Ended	1 Months Ended	4 Months Ended	12 Months Ended	4 Months Ended	7 Months Ended	1 Months Ended
	Nov. 28, 2012	Mar. 26, 2013	Dec. 10, 2012	Dec. 31, 2013	Jan. 14, 2013	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2013	Sep. 30, 2013	Sep. 30, 2012	Mar. 31, 2013	Aug. 12, 2013	Dec. 31, 2013	Feb. 14, 2014	Sep. 12, 2013	Jul. 23, 2014	Nov. 30, 2013	Dec. 31, 2012	Dec. 20, 2013	Mar. 21, 2014	Nov. 30, 2012	Mar. 22, 2012	Aug. 03, 2006	Jan. 31, 2013
Class of Stock [Line Items]
Common stock, shares authorized (in shares)						180,000,000	150,000,000	150,000,000	150,000,000		100,000,000									150,000,000
Common stock, par value (in dollars per share)						$0.00	$0.00	$0.00	$0.00
Common stock, shares issued (in shares)						101,667,409	92,716,562	92,716,562	92,716,562
Common stock, shares outstanding (in shares)						101,667,409	92,716,562	92,716,562	92,716,562
Preferred stock, shares authorized (in shares)											15,000,000
Preferred Stock, Par or Stated Value Per Share						$0.00					$0.00
Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized						$360,300
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant						3,084,425
Debt Conversion, Original Debt, Amount						0	11,273,100	11,275,000
Share-based Compensation						1,008,700	1,257,300
Volume Of Shares Traded On Open Market		283,400	15,000	180,000	36,700
Debt Instrument, Convertible, Conversion Price												$1
Total Stock Shares Authorized						195,000,000
Debt Conversion, Converted Instrument, Shares Issued							76,448,279	76,488,279
Debt Conversion Original Debt Interest Amount							1,661,000	1,661,100
Debt Conversion Original Debt Principal Amount							9,612,100	9,613,900
Gains (Losses) on Extinguishment of Debt, Total	556,300					1,105,200	556,300
Ten Vendors [Member]
Class of Stock [Line Items]
Debt Instrument, Convertible, Conversion Price							$0.25	$0.25	$0.25
Stock issued for purchase of common stock (in shares)									2,008,318
Stock Issued During Period, Value, New Issues									502,100
$1 Notes [Member]
Class of Stock [Line Items]
Debt Conversion, Original Debt, Amount							7,723,300
Debt Instrument, Convertible, Conversion Price							$1	$1	$1
Debt Conversion, Converted Instrument, Shares Issued							30,893,419
Debt Conversion Original Debt Interest Amount							1,359,400
$1 Notes [Member] | Before Amendment [Member]
Class of Stock [Line Items]
Debt Instrument, Convertible, Conversion Price							$1	$1	$1
$1 Notes [Member] | After Amendment [Member]
Class of Stock [Line Items]
Debt Instrument, Convertible, Conversion Price							$0.25	$0.25	$0.25
October 2012 Note [Member]
Class of Stock [Line Items]
Convertible Notes Payable										398,100											2,000,000
Debt Instrument, Convertible, Conversion Price																					$0.05
Debt Conversion, Converted Instrument, Shares Issued										40,000
Private Placement [Member]
Class of Stock [Line Items]
Proceeds from Issuance of Private Placement		2,500,000
Forfeiture and Exchange Agreements [Member]
Class of Stock [Line Items]
Share-based Compensation										165,700
Stock Issued During Period, Shares, Share-based Compensation, Net of Forfeitures										165,666
Debt Instrument, Convertible, Conversion Price						$0.05
Extinguishment Of Salaries Percentage										50.00%
Plan 2012 [Member]
Class of Stock [Line Items]
Common Stock, Capital Shares Reserved for Future Issuance																						333,334
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures, Total						11,915,575
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number																						42,670
Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized Exercise Price																						$3
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized																		5,500,000
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price				$0.25
Plan 2006 [Member]
Class of Stock [Line Items]
Common Stock, Capital Shares Reserved for Future Issuance																							667,667
Amendment Plan 2012 [Member]
Class of Stock [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures, Total											250,000
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized		15,000,000
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price											$0.25
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period											36 months
Amendment Plan 2006 [Member]
Class of Stock [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number, Beginning Balance						501,924
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number						6,132
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant						87,786
Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercises In Period						70,825
Common Stock [Member]
Class of Stock [Line Items]
Warrants Exercised						608,309
Warrants Issued Exercise Price						$0.05
Stock Issued During Period Shares Warrant Exercise						564,467
Warrant [Member]
Class of Stock [Line Items]
Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price						$3.07	$3.03	$3.03	$3.03
Warrant [Member] | October 2012 Note [Member]
Class of Stock [Line Items]
Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price			$0.05
Minimum [Member]
Class of Stock [Line Items]
Per Share Value Of Shares Traded On Open Market		$0.46	$0.76	$0.30	$0.49
Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price						$0.05
Debt Instrument, Convertible, Threshold Trading Days		22	11	51	21
Minimum [Member] | Plan 2012 [Member]
Class of Stock [Line Items]
Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price						$0.05
Minimum [Member] | Plan 2006 [Member]
Class of Stock [Line Items]
Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price						$3.60
Maximum [Member]
Class of Stock [Line Items]
Per Share Value Of Shares Traded On Open Market		$0.83	$0.83	$1.74	$2.50
Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price						$9.90
Debt Instrument, Convertible, Threshold Trading Days		58	48	93	50
Maximum [Member] | Plan 2012 [Member]
Class of Stock [Line Items]
Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price						$0.25
Maximum [Member] | Plan 2006 [Member]
Class of Stock [Line Items]
Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price						$32.70
Monarch Capital Group Llc [Member]
Class of Stock [Line Items]
Common stock, par value (in dollars per share)						$0.00	$0.00	$0.00	$0.00
Debt Instrument, Face Amount						300,000	520,000	520,000	520,000
Monarch Capital Group Llc [Member] | October 2012 Note [Member]
Class of Stock [Line Items]
Debt Instrument, Face Amount							60,000	60,000	60,000
Monarch Capital Group Llc [Member] | Private Placement [Member]
Class of Stock [Line Items]
Common stock, par value (in dollars per share)							$0.00	$0.00	$0.00
Debt Instrument, Face Amount							380,000	380,000	380,000
Mr. Tony Pullen [Member] | October 2012 Note [Member]
Class of Stock [Line Items]
Debt Instrument, Face Amount							350,000	350,000	350,000
Consultants [Member]
Class of Stock [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period							36 months
Consultants [Member] | Plan 2012 [Member]
Class of Stock [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross						425,000
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price						$0.26
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period						36 months
Sail Venture Partners [Member] | October 2012 Note [Member]
Class of Stock [Line Items]
Debt Conversion Original Debt Principal Amount							100,000
Accredited Third Party Investor [Member]
Class of Stock [Line Items]
Proceeds from Issuance of Private Placement							2,000,000					827,500
Accredited Third Party Investor [Member] | Private Placement [Member]
Class of Stock [Line Items]
Proceeds from Issuance of Private Placement		695,000
Key Consultants [Member]
Class of Stock [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures, Total							1,600,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross													1,600,000
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period													36 months
Key Consultants [Member] | Warrant [Member]
Class of Stock [Line Items]
Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price				$0.05									0.04718
Accredited Investor [Member]
Class of Stock [Line Items]
Proceeds from Issuance of Private Placement				2,047,500
D&D Securities Inc [Member]
Class of Stock [Line Items]
Common stock, par value (in dollars per share)						$0.00
Debt Instrument, Face Amount						115,000
Five Accredited Investors [Member]
Class of Stock [Line Items]
Stock issued for purchase of common stock (in shares)							800,000
SAIL Capital Partners [Member] | Senior Notes [Member]
Class of Stock [Line Items]
Debt Instrument, Convertible, Conversion Price																								$1
Debt Conversion, Converted Instrument, Shares Issued							1,469,816
Debt Conversion Original Debt Interest Amount							219,800
Debt Conversion Original Debt Principal Amount							1,250,000
Twenty Nine Accredited Investors [Member] | Private Placement [Member]
Class of Stock [Line Items]
Stock issued for purchase of common stock (in shares)														5,900,000
Proceeds from Issuance of Private Placement														1,475,000
Zachary McAdoo [Member]
Class of Stock [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number																						8,334
Maurice DeWald [Member]
Class of Stock [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number																						8,334
Robert Follman [Member]
Class of Stock [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized			5,500,000																			333,334
Andrew Sassine [Member]
Class of Stock [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized			5,500,000																			333,334
Richard Turner [Member]
Class of Stock [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized			5,500,000																			333,334
Thomas Tierney [Member]
Class of Stock [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized			5,500,000																			333,334
Thirty Nine Accredited [Member] | Private Placement [Member]
Class of Stock [Line Items]
Stock issued for purchase of common stock (in shares)															12,180,000
Proceeds from Issuance of Private Placement															3,045,000
Eight Accredited Investors [Member] | Private Placement [Member]
Class of Stock [Line Items]
Stock issued for purchase of common stock (in shares)																1,040,000
Proceeds from Issuance of Private Placement																260,000
Consultants and Staff Excluding Managers [Member]
Class of Stock [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures, Total																	700,000
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price																	$0.25
George Carpenter [Member]
Class of Stock [Line Items]
Extinguishment Of Salaries				98,000
Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercises In Period				435,000
George Carpenter [Member] | Plan 2012 [Member]
Class of Stock [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross																		1,200,000
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage																		12.50%
Michael Darkoch [Member] | Plan 2012 [Member]
Class of Stock [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross																		920,000
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage																		12.50%
Three Existing and Four New Board [Member] | Plan 2012 [Member]
Class of Stock [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross																		250,000
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price																		0.04718
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period																		36 months
Five Former Directors [Member] | Plan 2012 [Member]
Class of Stock [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross																		25,000
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price																		0.04718
Staff [Member]
Class of Stock [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures, Total							1,960,000
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price							$0.05
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period							48 months
Mr Paul Buck [Member]
Class of Stock [Line Items]
Extinguishment Of Salaries				106,500
Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercises In Period				470,000
Mr Paul Buck [Member] | Plan 2012 [Member]
Class of Stock [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross																		1,400,000
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage																		12.50%
Stewart Navarre [Member]
Class of Stock [Line Items]
Extinguishment Of Salaries				83,600
Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercises In Period				385,000
Brian MacDonald [Member]
Class of Stock [Line Items]
Extinguishment Of Salaries				66,700
Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercises In Period				310,000
Two Creditors [Member] | Common Stock [Member]
Class of Stock [Line Items]
Debt Conversion, Original Debt, Amount						1,466,800
Debt Conversion, Converted Instrument, Shares Issued						1,446,380
Debt Conversion, Converted Instrument, Amount																			361,500
Gains (Losses) on Extinguishment of Debt, Total																			$1,105,200

INCOME_TAXES_Details

INCOME TAXES (Details)	12 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Income Taxes [Line Items]
Federal income tax (benefit) at statutory rates	-34.00%	-34.00%
Stock-based compensation	-0.20%	3.00%
Nondeductible interest expense	0.00%	4.00%
Extinguishment of debt	1.50%	-2.00%
Change in valuation allowance	-5.00%	3.00%
True-ups and other adjustments	-26.90%	0.00%
State tax benefit	-3.40%	9.00%
Inducement to convert	0.00%	17.00%

INCOME_TAXES_Details1

INCOME TAXES (Details1) (USD $)	Sep. 30, 2014	Sep. 30, 2013
Deferred income tax assets:
Net operating loss carryforward	$13,083,200	$15,370,600
Deferred interest, consulting and compensation liabilities	1,529,800	1,168,300
Amortization	0	2,900
Deferred income tax assets - other	5,800	4,300
Deferred Tax Assets, Gross	14,618,800	16,546,100
Deferred income tax liabilities-other	-1,600	0
Deferred income tax asset-net before valuation allowance	14,617,200	16,546,100
Valuation allowance	-14,617,200	-16,546,100
Deferred income tax assetBnet	$0	$0

INCOME_TAXES_Details_Textual

INCOME TAXES (Details Textual) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Sep. 30, 2014
Domestic Tax Authority [Member]
Operating Loss Carryforwards [Line Items]
Operating Loss Carryforwards	$31.60
Operating Loss Carryforwards, Expiration Date	30-Sep-34
State and Local Jurisdiction [Member]
Operating Loss Carryforwards [Line Items]
Operating Loss Carryforwards	$51
Operating Loss Carryforwards, Expiration Date	30-Sep-34

RELATED_PARTY_TRANSACTIONS_Det

RELATED PARTY TRANSACTIONS (Details Textual) (USD $)	12 Months Ended		24 Months Ended	3 Months Ended	12 Months Ended	11 Months Ended	16 Months Ended	6 Months Ended	0 Months Ended		17 Months Ended	0 Months Ended	1 Months Ended	0 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2013	Mar. 26, 2013	Sep. 30, 2012	Jul. 08, 2014	Jul. 08, 2014	Aug. 28, 2013	Jul. 08, 2014	Feb. 12, 2014	Sep. 30, 2014	Apr. 02, 2013	Aug. 30, 2013	Jan. 28, 2014	Jul. 11, 2014	Aug. 12, 2013	Nov. 30, 2012	Oct. 26, 2012	Feb. 29, 2012
Related Party Transaction [Line Items]
Debt Conversion Original Debt Principal Amount		$9,612,100	$9,613,900
Debt Conversion Original Debt Interest Amount		1,661,000	1,661,100
Debt Conversion, Original Debt, Amount	0	11,273,100	11,275,000
Debt Conversion, Converted Instrument, Shares Issued		76,448,279	76,488,279
Debt Instrument, Convertible, Conversion Price																$1
Proceeds From Purchase Of Common Stock	1,691,000	2,958,800
Debt Instrument, Convertible, Terms of Conversion Feature	As the original conversion terms of the notes were at $1 into one share of common stock with a fair value of $0.25, consequently, the three additional shares offered on conversion at $0.25 each represent the inducement to convert.
Accounts Payable, Current	868,900	2,493,200	2,493,200								868,900
Two Thousand And Twelve Plan [Member]
Related Party Transaction [Line Items]
Weighted Average Exercise Price, Granted	$0.25
Private Placement [Member]
Related Party Transaction [Line Items]
Proceeds From Issuance Of Private Placement				2,500,000
$1 Notes [Member]
Related Party Transaction [Line Items]
Debt Conversion Original Debt Interest Amount		1,359,400
Debt Conversion, Original Debt, Amount		7,723,300
Debt Conversion, Converted Instrument, Shares Issued		30,893,419
Debt Instrument, Convertible, Conversion Price		$1	$1
$1 Notes [Member] | Before Amendment [Member]
Related Party Transaction [Line Items]
Debt Instrument, Convertible, Conversion Price		$1	$1
$1 Notes [Member] | After Amendment [Member]
Related Party Transaction [Line Items]
Debt Instrument, Convertible, Conversion Price		$0.25	$0.25
Consulting Agreement [Member]
Related Party Transaction [Line Items]
Debt Instrument, Convertible, Number of Equity Instruments		850,000
Weighted Average Exercise Price, Granted		$0.05
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period		36 months
Forfeiture and Exchange Agreements [Member]
Related Party Transaction [Line Items]
Debt Instrument, Convertible, Conversion Price	$0.05										$0.05
Single Financing Transaction Minimum Proceeds	5,000,000
October 2012 Note [Member]
Related Party Transaction [Line Items]
Notes Payable, Related Parties																		90,000
Short-term Debt					400,000
Debt Conversion, Converted Instrument, Shares Issued					40,000
Debt Instrument, Convertible, Conversion Price																	$0.05
September 2014 Notes [Member]
Related Party Transaction [Line Items]
Debt Instrument, Face Amount	2,500,000										2,500,000
Debt Instrument, Convertible, Conversion Price	$0.25										$0.25
Debt Instrument, Convertible, Terms of Conversion Feature	(i) automatically upon the closing of a qualified offering of no less than $5 million at a conversion price equal to the lesser of $0.25 or 70% of the lowest cost of Common Stock offered by the Company, but in no event less than $0.10 per share or (ii) voluntarily within 15 days of maturity at the lesser of a conversion price equal to $0.25 or the lowest cost of Common Stock offered by the Company, but in no event less than $0.10 per share.
February 2012 Notes [Member] | Consulting Agreement [Member]
Related Party Transaction [Line Items]
Unsecured Debt, Current																			90,000
February 2012 Notes [Member] | Consulting Agreement [Member] | Unsecured Convertible Notes Payable [Member]
Related Party Transaction [Line Items]
Debt Conversion Original Debt Principal Amount		90,000
John Pappajohn [Member]
Related Party Transaction [Line Items]
Debt Conversion Original Debt Principal Amount	1,511,700
Debt Conversion Original Debt Interest Amount	317,900
Debt Conversion, Converted Instrument, Shares Issued	7,318,229
Stock Issued During Period, Shares, New Issues		400,000
Proceeds From Issuance Of Private Placement		100,000
Shares Issued, Price Per Share		$0.25	$0.25
John Pappajohn [Member] | October 2012 Note [Member]
Related Party Transaction [Line Items]
Short-term Debt	200,000										200,000
Debt Instrument, Face Amount	500,000										500,000
Proceeds from Convertible Debt	300,000
John Pappajohn [Member] | September 2014 Notes [Member]
Related Party Transaction [Line Items]
Debt Instrument, Face Amount	200,000										200,000
Debt Instrument, Convertible, Terms of Conversion Feature	(i) automatically upon the closing of a qualified offering of no less than $5 million at a conversion price equal to the lesser of $0.25 or 70% of the lowest cost of Common Stock offered by the Company, but in no event less than $0.10 per share or (ii) voluntarily within 15 days of maturity at the lesser of a conversion price equal to $0.25 or the lowest cost of Common Stock offered by the Company, but in no event less than $0.10 per share.
Mr Andy Sassine [Member]
Related Party Transaction [Line Items]
Debt Conversion Original Debt Principal Amount	700,000
Debt Conversion Original Debt Interest Amount	174,600
Debt Conversion, Converted Instrument, Shares Issued	3,498,200
Follman Trust [Member] | Unregistered Stock [Member] | Private Placement [Member]
Related Party Transaction [Line Items]
Stock Issued During Period, Value, New Issues						100,000
Stock Issued During Period, Shares, New Issues						400,000
Proceeds From Issuance Of Private Placement						100,000
Share Price						$0.25	$0.25		$0.25
Follman Trust [Member] | Unregistered Stock [Member] | Aggregate of Four Tranches [Member] | Private Placement [Member]
Related Party Transaction [Line Items]
Proceeds From Issuance Of Private Placement						500,000
Share Price						$0.25	$0.25		$0.25
Stock Issued During Period, Shares, Purchase of Assets						2,000,000
Follman Trust [Member] | October 2012 Note [Member]
Related Party Transaction [Line Items]
Debt Instrument, Face Amount	200,000										200,000
Debt Conversion, Converted Instrument, Shares Issued	4,491,310
Debt Instrument, Convertible, Conversion Price	$0.05										$0.05
Extuple Limited Partnership [Member] | October 2012 Note [Member]
Related Party Transaction [Line Items]
Debt Conversion, Original Debt, Amount		150,000
Debt Conversion, Converted Instrument, Shares Issued		3,449,555
Debt Instrument, Convertible, Conversion Price		$0.05	$0.05
Extuple Limited Partnership [Member] | October 2012 Notes One [Member]
Related Party Transaction [Line Items]
Debt Instrument, Face Amount		200,000	200,000
Debt Conversion, Original Debt, Amount		50,000
Debt Conversion, Converted Instrument, Shares Issued		1,121,237
Debt Instrument, Convertible, Conversion Price		$0.05	$0.05
Sail 2010 Co-Investment Partners [Member] | October 2012 Note [Member]
Related Party Transaction [Line Items]
Notes Payable, Related Parties																		20,000
Sail 2011 Co-Investment Partners [Member] | October 2012 Note [Member]
Related Party Transaction [Line Items]
Notes Payable, Related Parties																		20,000
Sail Venture Partners [Member] | October 2012 Note [Member]
Related Party Transaction [Line Items]
Debt Conversion Original Debt Principal Amount		100,000
Notes Payable, Related Parties																		50,000
Andrew Sassine [Member] | October 2012 Note [Member]
Related Party Transaction [Line Items]
Debt Instrument, Face Amount		25,000	25,000
Debt Conversion, Converted Instrument, Shares Issued		550,021
Debt Instrument, Convertible, Conversion Price		$0.05	$0.05
Debt Instrument, Convertible, Latest Date		30-Apr-13
Tierney Family Trust [Member] | Unregistered Stock [Member] | Private Placement [Member]
Related Party Transaction [Line Items]
Stock Issued During Period, Value, New Issues							100,000
Stock Issued During Period, Shares, New Issues							400,000
Proceeds From Issuance Of Private Placement							100,000
Share Price						$0.25	$0.25		$0.25
Tierney Family Trust [Member] | Unregistered Stock [Member] | Aggregate of Six Tranches [Member] | Private Placement [Member]
Related Party Transaction [Line Items]
Proceeds From Issuance Of Private Placement							700,000
Share Price						$0.25	$0.25		$0.25
Stock Issued During Period, Shares, Purchase of Assets							2,800,000
Tierney Family Trust [Member] | October 2012 Note [Member]
Related Party Transaction [Line Items]
Debt Instrument, Face Amount		200,000	200,000
Debt Conversion, Original Debt, Amount		200,000
Debt Conversion, Converted Instrument, Shares Issued		4,403,349
Debt Instrument, Convertible, Conversion Price		$0.05	$0.05
Tierney Family Trust [Member] | September 2014 Notes [Member]
Related Party Transaction [Line Items]
Debt Instrument, Face Amount	200,000										200,000
Debt Instrument, Convertible, Terms of Conversion Feature	(i) automatically upon the closing of a qualified offering of no less than $5 million at a conversion price equal to the lesser of $0.25 or 70% of the lowest cost of Common Stock offered by the Company, but in no event less than $0.10 per share or (ii) voluntarily within 15 days of maturity at the lesser of a conversion price equal to $0.25 or the lowest cost of Common Stock offered by the Company, but in no event less than $0.10 per share.
John Pappajohn One [Member] | October 2012 Note [Member]
Related Party Transaction [Line Items]
Debt Conversion, Original Debt, Amount	200,000
Debt Conversion, Converted Instrument, Shares Issued	4,300,551
Debt Instrument, Convertible, Conversion Price	$0.05										$0.05
John Pappajohn Two [Member] | October 2012 Note [Member]
Related Party Transaction [Line Items]
Debt Conversion, Original Debt, Amount	300,000
Debt Conversion, Converted Instrument, Shares Issued	6,538,258
Debt Instrument, Convertible, Conversion Price	$0.05										$0.05
Mr. Larry Hopfenspirger [Member]
Related Party Transaction [Line Items]
Employee Compensation Amount Of Waiver	106,500
Sail Venture Partners L P [Member]
Related Party Transaction [Line Items]
Debt Conversion Original Debt Principal Amount		1,440,000
Debt Conversion Original Debt Interest Amount		226,200
Debt Conversion, Converted Instrument, Shares Issued		5,631,699
Sail Venture Partners L P [Member] | Six January 2011 Notes [Member]
Related Party Transaction [Line Items]
Debt Conversion Original Debt Principal Amount		1,000,000
Debt Conversion Original Debt Interest Amount		166,500
Debt Conversion, Converted Instrument, Shares Issued		1,166,503
Debt Instrument, Convertible, Conversion Price		$1	$1
Sail Venture Partners L P [Member] | Four October 2012 Note [Member]
Related Party Transaction [Line Items]
Debt Conversion Original Debt Principal Amount		190,000
Debt Conversion Original Debt Interest Amount		6,400
Debt Conversion, Converted Instrument, Shares Issued		4,161,883
Debt Instrument, Convertible, Conversion Price		$0.05	$0.05
Sail Venture Partners L P [Member] | October 2010 Notes [Member]
Related Party Transaction [Line Items]
Debt Conversion Original Debt Principal Amount	250,000
Debt Conversion Original Debt Interest Amount		53,300
Debt Conversion, Converted Instrument, Shares Issued		303,313
Debt Instrument, Convertible, Conversion Price		$1	$1
Mr Paul Buck [Member]
Related Party Transaction [Line Items]
Debt Conversion Original Debt Principal Amount	75,000
Debt Conversion Original Debt Interest Amount	14,900
Debt Conversion, Converted Instrument, Shares Issued	359,450
Mr Paul Buck [Member] | Two Thousand And Twelve Plan [Member]
Related Party Transaction [Line Items]
Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Grants In Period, Gross	470,000
Mr Paul Buck [Member] | Unregistered Stock [Member] | Private Placement [Member]
Related Party Transaction [Line Items]
Share Price								$0.25
Mr Paul Buck [Member] | Unregistered Stock [Member] | Aggregate of Two Tranches [Member] | Private Placement [Member]
Related Party Transaction [Line Items]
Stock Issued During Period, Value, New Issues								12,500
Stock Issued During Period, Shares, New Issues								100,000
Proceeds From Issuance Of Private Placement								25,000
Share Price								$0.25
Mr Paul Buck [Member] | Common Stock [Member]
Related Party Transaction [Line Items]
Common Stock, Value, Subscriptions						12,500	12,500		12,500	25,000
Mr Paul Buck [Member] | Common Stock [Member] | Stock Subscription Agreement [Member]
Related Party Transaction [Line Items]
Stock Issued During Period, Value, New Issues									12,500	25,000
Stock Issued During Period, Shares, New Issues									50,000	100,000
Shares Issued, Price Per Share						$0.25	$0.25		$0.25	$0.25
Mr Paul Buck [Member] | Forfeiture and Exchange Agreements [Member]
Related Party Transaction [Line Items]
Employee Compensation Amount Of Waiver					66,083
Shares Issued In Consideration For Waiver					66,083
Decision Calculus Associates [Member] | October 2012 Note [Member]
Related Party Transaction [Line Items]
Stock Issued During Period, Value, New Issues											155,000
Zach McAdoo [Member]
Related Party Transaction [Line Items]
Debt Conversion Original Debt Principal Amount	380,000
Debt Conversion Original Debt Interest Amount	57,200
Debt Conversion, Converted Instrument, Shares Issued	1,748,720
Sail VM [Member] | Common Stock [Member]
Related Party Transaction [Line Items]
Stock Issued During Period, Value, New Issues		45,500
Stock Issued During Period, Shares, New Issues		181,974
Shares Issued, Price Per Share		$0.25	$0.25
Equity Dynamics [Member]
Related Party Transaction [Line Items]
Accrued Professional Fees		200,000	200,000
Five Accredited Investors [Member]
Related Party Transaction [Line Items]
Value Of Debt Assigned		200,000	200,000
Stock Issued During Period, Shares, New Issues		800,000
Shares Issued, Price Per Share		$0.25	$0.25
George Carpenter [Member]
Related Party Transaction [Line Items]
Employee Compensation Amount Of Waiver	98,000
Accounts Payable, Current	15,000										15,000
George Carpenter [Member] | Two Thousand And Twelve Plan [Member]
Related Party Transaction [Line Items]
Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Grants In Period, Gross	435,000
George Carpenter [Member] | Forfeiture and Exchange Agreements [Member]
Related Party Transaction [Line Items]
Employee Compensation Amount Of Waiver					56,250
Shares Issued In Consideration For Waiver					56,250
George Carpenter [Member] | October 2012 Note [Member]
Related Party Transaction [Line Items]
Debt Instrument, Face Amount		50,000	50,000
Debt Conversion, Converted Instrument, Shares Issued		1,091,299
Debt Instrument, Convertible, Conversion Price		$0.05	$0.05
Debt Instrument, Convertible, Latest Date		27-Mar-13
Michael Darkoch [Member] | Forfeiture and Exchange Agreements [Member]
Related Party Transaction [Line Items]
Employee Compensation Amount Of Waiver					43,333
Shares Issued In Consideration For Waiver					43,333
Omans [Member] | Common Stock [Member]
Related Party Transaction [Line Items]
Stock Issued During Period, Value, New Issues												300,000	100,000
Stock Issued During Period, Shares, New Issues												1,200,000	400,000
Share Price												$0.25	$0.25
Proceeds From Purchase Of Common Stock												300,000	100,000
Omans [Member] | October 2012 Note [Member]
Related Party Transaction [Line Items]
Debt Instrument, Face Amount		250,000	250,000
Debt Conversion, Converted Instrument, Shares Issued		5,500,212
Debt Instrument, Convertible, Conversion Price		$0.05	$0.05
Common Stock, Value, Subscriptions		250,000	250,000
Number Of Share Held In Own Name		800,000	800,000
Number Of Shares Held In Affiliate Name		200,000	200,000
Omans [Member] | October 2012 Note [Member] | Stock Subscription Agreement [Member]
Related Party Transaction [Line Items]
Stock Issued During Period, Value, New Issues		250,000
Stock Issued During Period, Shares, New Issues		1,000,000
Shares Issued, Price Per Share		$0.25	$0.25
Mr and Mrs Carpenter [Member] | Common Stock [Member]
Related Party Transaction [Line Items]
Common Stock, Value, Subscriptions														50,000	12,500
Stock Issued During Period, Value, New Issues														50,000
Mr and Mrs Carpenter [Member] | Common Stock [Member] | Stock Subscription Agreement [Member]
Related Party Transaction [Line Items]
Stock Issued During Period, Value, New Issues															12,500
Stock Issued During Period, Shares, New Issues														200,000	50,000
Shares Issued, Price Per Share														$0.25	$0.25
Stewart Navarre [Member]
Related Party Transaction [Line Items]
Employee Compensation Amount Of Waiver	83,600
Stewart Navarre [Member] | Two Thousand And Twelve Plan [Member]
Related Party Transaction [Line Items]
Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Grants In Period, Gross	385,000
Brian MacDonald [Member]
Related Party Transaction [Line Items]
Employee Compensation Amount Of Waiver	66,700
Brian MacDonald [Member] | Two Thousand And Twelve Plan [Member]
Related Party Transaction [Line Items]
Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Grants In Period, Gross	310,000
SAIL Pre-Exit Acceleration fund, L.P [Member]
Related Party Transaction [Line Items]
Stock Issued During Period, Shares, New Issues	40,000
Proceeds From Purchase Of Common Stock	$10,000
Shares Issued, Price Per Share	$0.25										$0.25
Oman Ventures LLC [Member] | September 2014 Notes [Member]
Related Party Transaction [Line Items]
Debt Instrument, Convertible, Terms of Conversion Feature	(i) automatically upon the closing of a qualified offering of no less than $5 million at a conversion price equal to the lesser of $0.25 or 70% of the lowest cost of Common Stock offered by the Company, but in no event less than $0.10 per share or (ii) voluntarily within 15 days of maturity at the lesser of a conversion price equal to $0.25 or the lowest cost of Common Stock offered by the Company, but in no event less than $0.10 per share.

LOSS_PER_SHARE_Details

LOSS PER SHARE (Details) (USD $)	12 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Net Loss for computation of basic and diluted net loss per share:
From continuing operations	($2,660,100)	($10,888,000)
From discontinued operations	-2,700	-19,400
Net loss	($2,662,800)	($10,907,400)
Basic and Diluted net loss per share:
From continuing operations (in dollars per share)	($0.03)	($0.14)
From discontinued operations (in dollars per share)	$0	$0
Basic net loss per share (in dollars per share)	($0.03)	($0.14)
Basic and Diluted weighted average shares outstanding	99,326,519	75,800,179
Convertible debt [Member]
Basic and Diluted net loss per share:
Anti-dilutive common equivalent shares not included in the computation of dilutive net loss per share:	137,500	22,468,186
Warrants [Member]
Basic and Diluted net loss per share:
Anti-dilutive common equivalent shares not included in the computation of dilutive net loss per share:	1,139,415	1,163,976
Options [Member]
Basic and Diluted net loss per share:
Anti-dilutive common equivalent shares not included in the computation of dilutive net loss per share:	11,930,872	8,009,536

COMMITMENTS_AND_CONTINGENT_LIA2

COMMITMENTS AND CONTINGENT LIABILITIES (Details) (USD $)	Sep. 30, 2014
Operating Lease Obligations
Operating Lease Obligations, less than 1 year	$49,200
Operating Lease Obligations, 1 to 3 years	18,100
Operating Lease Obligations, 3-5 years	0
Operating Lease Obligations, More than 5 years	0
Operating Lease Obligations, Total	67,300
Capital Lease Obligations
Capital Lease Obligations, less than 1 year	3,500
Capital Lease Obligations, 1 to 3 years	2,500
Capital Lease Obligations, 3-5years	0
Capital Lease Obligations, More than 5 years	0
Capital Lease Obligations, Total	6,000
Total Lease Obligations
Total, less than 1 year	52,700
Total, 1 to 3 years	20,600
Total, 3-5 years	0
Total, More than 5 years	0
Total	$73,300

COMMITMENTS_AND_CONTINGENT_LIA3

COMMITMENTS AND CONTINGENT LIABILITIES (Details Textual) (USD $)	12 Months Ended		1 Months Ended	3 Months Ended	0 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Jan. 31, 2013	Mar. 31, 2013	Nov. 08, 2010	Apr. 24, 2013
Other Commitments [Line Items]
Operating Leases, Rent Expense, Net	$45,000	$47,700
Capital Leases Future Minimum Payments Due	6,000
Lease Commitment [Member] | Promissory Note [Member]
Other Commitments [Line Items]
Debt Instrument, Face Amount	50,000
Debt Instrument, Interest Rate, Stated Percentage	5.00%
Debt Instrument, Payment Terms	13 payments over 12 months.
Lease Commitment [Member] | Promissory Note [Member] | Debt Instrument, Redemption, Period One [Member]
Other Commitments [Line Items]
Debt Instrument, Frequency of Periodic Payment	monthly
Lease Commitment [Member] | Promissory Note [Member] | Debt Instrument, Redemption, Period Two [Member]
Other Commitments [Line Items]
Debt Instrument, Frequency of Periodic Payment	monthly
Mr Brandt [Member]
Other Commitments [Line Items]
Loss Contingency, Damages Sought, Value		250,000	9,000,000	170,000
Headquarters and Neurometric Information Services [Member]
Other Commitments [Line Items]
Lessor Leasing Arrangements, Operating Leases, Term of Contract	24 months
Operating Leases Monthly Lease Payments	4,349
Operating Leases, Future Minimum Payments, Due in Two Years	4,523
Clinical Services [Member]
Other Commitments [Line Items]
Lessor Leasing Arrangements, Operating Leases, Term of Contract	37 months
Operating Leases Monthly Lease Payments	5,100
Eeg Equipment one [Member]
Other Commitments [Line Items]
Operating Leases Monthly Lease Payments	412
Proceeds from Long-term Capital Lease Obligations					15,900
Capital Lease Term	48 months
Eeg Equipment Two [Member]
Other Commitments [Line Items]
Operating Leases Monthly Lease Payments	325
Proceeds from Long-term Capital Lease Obligations						8,900
Capital Lease Term	36 months
Capital Leases Future Minimum Payments Due	6,000
Capital Leases, Future Minimum Payments Due in Two Years	3,500
Capital Leases, Future Minimum Payments Due in Three Years	$2,500

SIGNIFICANT_CUSTOMERS_Details_

SIGNIFICANT CUSTOMERS (Details Textual) (Customer Concentration Risk [Member])	12 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Sales Revenue, Services, Net [Member]
Concentration Risk, Percentage	68.00%	51.00%
Accounts Receivable [Member]
Concentration Risk, Percentage	53.00%	50.00%